key: cord-0038390-rkxlm4v9 authors: nan title: Cumulative Index 1981, 1982, and 1983 Index date: 2016-04-06 journal: Med Clin North Am DOI: 10.1016/s0025-7125(16)31158-0 sha: 22a61c3bdfc8fc4fe7da9138177b69e9695c9cc0 doc_id: 38390 cord_uid: rkxlm4v9 nan Arachidonic acid (Continued) in prostaglandin synthesis, 1981: July, 716--720 metabolites, as nlediators of hypersensitivity and inflammation, 1981: July, 809-828 . ARDS. See Respiratory distress syndrolne, adult. Arrhythmia(s). See also specific disorders. cardiac, chronic airflow obstruction : May, 554 in aged, 1983 : March, 387-390 ventricular, in acute respiratory failure, 1983 : May, 735 Arteritis, temporal, 1982 : July, 952 in aged, 1982 Arthritis, acute, 1981 : Jan., 177-188 digital, in psoriasis, 1982 : July, 773-774 in aged, 1982 : Sept., 1033 -1036 bronchial reactivity and, 1981 : May, 475 bronchoconstriction of, 1981 control of, 1981 : Sept., 1033 -1043 corticosteroids in, 1981 : Sept., 1059 drug therapy for, 1981 : May, 579-613 eosinophilia in, 1981 immunotherapy for, 1981 : Sept., 990-993 nlast cells in, 1981 -1018 nledications for, 1981 -1040 neurogenic mechanisms in, 1981 : Sept., 1023 occupational, 1981 : May, 697-700 pathogenesis and pathophysiology of, cellular mechanisms in, 1981 : Sept., 1013 -1031 pregnancy and, 1983 : May, 682 Astrovirus(es), 1982 : May, 587-588 Astrovirus infection(s), gastroenteric, 1983 Sept., 1047 Ataxia telangiectasia, 1981: Sept., 966 Atelectasis, radiographic features of, 1983 : Nov., 1321 Atherogenesis, arachidonic acid lnetabolisnl and, 1981 : July, 867-870 Atherogenic hyperlipoproteinenlia, 1982 March, 375-402 I~DEX Antimicrobial drug(s), comparative costs, 11)83: Jan., 174 in enteric infections, 1983: Jan., 214--216 oral, 1983: Jan., 57-98 . See also specific drug, as Penicillin. outpatient use, 1983: Jan., 3-16 prophylactic, 1983: Jan., 99-112 Antimicrobial therapy, administration : Jan., 9--10 choosing of appropriate agent, 1982 : Jan., 6--9 combination, 1982 : Jan., 17-24 liver disease and, 1982 : Jan., 257-266 monitoring, 1982 : Jan., 10--11 principles of, 1982 : Jan., 3-15 renal insufficiency and, 1982 : Jan., 267-281 resistance to, 1982 : Jan., 25-37 Antimonials, for parasitic infections, 1982 Jan., 249 Antimycotic agent(s), in dermatomycoses, 1982: July, 887-893 Antipseudomonas penicillins. See specific agent, such as Carbenicillin. Antip~ychotic drug(s), 1982: Sept., 993-1009 : March, 370--371 Antisera, viral, 1983 Antistaphylococcal penicillin(s), 1982: Jan., 51-60. See also Penicillins, antistaphy/ococcal. Antituberculous agent(s), 1983: Jan., 80--83 Antiviral drug(s). See Drug ( si, antidral or under specific agent, as Vidarabine. Antiviral therapy, 1982 : Jan., 235-244 Anxiety, in aged, 1982 : March, 368 in terminally ill, 1982 : Sept., 1016 , 1177 with acute illness, 1981 : Jan., 5 Aorta, aneurysms of, 1981 dissection, pain of, 11)81: Jan., ,59 Apnea, sleep, 1981: May, 558; : Sept., 980--982 in aged, 1983 : March, 424 with high-frequency ventilation, 1983 : May, 638 Apoplexy, pituitary, 1981 : Jan .. 105-116 Apoprotein B, overproduction, in hypertriglyceridemia, 1982 : 1-.Iarch, 523-525 Apoprotein E phenotypes, prevalence in population, 1982 : March, 445-447 Apoprotein E polymorphism, biochemical genetics, 1982 : }'larch, 442-446 Appendix, ulcerations, due to Yersinia infection, 1982 cardiac, chronic airflow obstruction and, 11)81. }, Iay, 554 in aged, 1983 : March, 387-390 ventricular, in acute respiratory failure, 1983 : May, 735 Arteritis, temporal, 1982 : July, 952 in aged, 1982 Arthritis, acute, 1981 : Jan., 177-188 digital, in psoriasis, 1982 : July, 773-774 in aged, 1982 : Sept., 1047 -1052 rheumatoid. See Rheumatoid arthritis. Articulation. See Joint. Ascariasis, drug therapy for, 1982 : May, 724--729 Aspergillosis, bronchopulmonary, allergic, 1981 , 1061 Aspergillus pneumonia, 1983 1244--1245 Aspirin. See Acetylsalicylic acid. : },Iay, 456 acute, 1983 : May, 669-684 airway hyperreactivity in, 1981: Sept., 1024--1026 assessment oC 1981: Sept., 1033 -1036 bronchial reactivity and, 1981 : May, 47.5 bronchoconstriction of, 1981 control of, 1981 : Sept., 1033 -1043 corticosteroids in, 1981 : Sept., 1059 drug therapy for, 1981 : },Iay, 579-613 eosinophilia in, 1981 immunotherapy for, 1981 : Sept., 990--993 mast cells in, 1981 --1018 medications for, 1981 -1040 neurogenic mechanisms in, 1981 : Sept., 1023 occupational, 1981 : May, 697-700 pathogenesis and pathophysiology of, cellular mechanisms in, 1981 : Sept., 1013 -1031 pregnancy and, 198.3: May, 682 Astrovirus(es), 1982 : May, .587-588 Astrovirus infection(s), gastroenleric, 1983 Sept" 1047 Ataxia telangiectasia, 1981: Sept., 966 Atelectasis, radiographic features of, 1983 : Nov., 1321 Atherogenesis, arachidonic acid metabolism and, 1981 : July, 867-870 Atherogenic hyperlipoproteinemia, 1982 March, 375-402 Atherosclerosis, high density lipoproteins and, 1982 : March, 331, 390 in diabetics, 1982 : Nov., 1347 in dogs, I)-very low density lipoproteins and, 1982 : March, 393-395 in familial dysbetalipoproteinen1ia, 1982 : March, 450-451 in hyperlipidemia, 1982 : March, 331 LDL stimulation of cell growth and, 1982 March, 397 low density lipoproteins and, 1982 : March, 395-396 macrophage accumulation hypothesis, 1982 : March, 39~397 pathogenetic models, 1982 : March, 377 plasma triglycerides and, 1982 Athlete's foot, 1982: July, 878 Atopic disorders, immunotherapy of, 1981: Sept., 987-1012 adverse reactions to, 1981: Sept., 1002 selecting patients for, 1981: Sept., 998-1000 Autoimmune disorder(s). See also specific disorders, as Myasthenia gravis. : Nov., 1215 --1217 renal tubular acidosis and, 1983 : July, 872 Autosensitization, immunodeficiency and, 1981 : Sept., 960 Azlocillin, 1982 : Jan., 61-73 Azotemia, prerenal, 1981 : March, 414 BACAMPICILLIN, 1983 : Jan., 64-65 Bacillus Calmette-Guerin, prostaglandins and, 1981 : July, 836 Bacillus cereus, enterotoxigenic, 1982 : May, 605 Bacitracin, for antibiotic-associated pseudomembranous colitis, 1982 : May, 660--661 Bacteria, antibiotic-resistant, control of in hospitals, 1982 : Jan., 34-35 Bacterial infection(s), in aged, 1983 : March, 273-287 Bacterial intestinal infection, in immuno-compron1ised patient, 1982 : May, 747 Bacterial overgrowth syndromes, 1982 . See specific pathogens. Bacteriuria, asymptomatic, 1983 : Jan., 195 in aged, 1983 : March, 284-285, 452-453 Balantidiuln coli infection, treatment, 1982 May, 713 Balloon tamponade, for variceal : Nov., 1220 Barbiturates, overdose, management of, 1983 : Nov., 1288-1289 INDEX Barotraulna, puln10nary, in acute respiratory failure, 1983 : May, 694-695, 727-728 Bartter's syndrolne, 1981 : July, 895-898 prostaglandins and, 1981 . See Amlnonia; Bicarbonate. Basophils, in immediate hypersensitivity reactions, 1981 : Sept., 945-950 Bears disease, 1983 : Sept., 98~987 B-cell deficiency syndrolnes, 1982 : May, 744-746 Beclomethasone, 1981 : Sept., 1077 Behavioral therapy, in gastrointestinal diseases, 1981 : Nov., 1397 -1411 Benoxaprofen, for pain, 1982 Benzocaine, dermatitis from, 1981 : Sept., 1084 Benzodiazepine(s), in aged, 1982 -1035 : March, 374-375 Benzolan1ide, 1981 : March, 292 Benzoyl perOXide, dermatitis from, 1981 Sept., 1085 for acne, 1982: July, 857-858 Beta-adrenergic drug(s), effects, in : Nov., 1382 -1383 Beta 2 -agonists, 1981 in cor pul~onale, 1981: May, 514 Beta-Iactam antibiotic(s), resistance to, 1982: Jan., 28-31 Betamethasone, for asthn1a, 1981 : May, 602 Bethanechol, for gastroesophageal reflux, 1981 : Nov., 1228 Bicarbonate, concentration, in respiratory failure, 1983 : May, 645-656 Pco 2 and, in regulation of pH, 1983 : July, 800 in respiratory alkalosis, 1983 : July, 917-922 renal reabsorption of, 1981 : July, 753-768, 84~847 in n1etabolic alkalosis, 1983 : July,905-906 in renal failure, 1983 in renal tubular acidosis, 1983: July, 860--862 nephron sites of, 1983 : July, 763-767 serum, in mixed acid-base disorders, 1981 : March, 352-355 Bicarbonate buffer system, 1983 : July, 773 Bicarbonate-chloride exchange mechanislns. 1983 : July, 762-763 Bicarbonate therapy, alkalosis and, 1983 : July, 910--911 in ketoacidosis, 1983 : Nov., 1194 : July, 825-827 Biguanides, lactic acidosis and, 1983 : July, 822-823 Bile-acid binding resins, for hypercholesterolemia, 1982 : March, 540-542 Atherosclerosis, high density Iipoproteins and, 1982 : March, 331, :390 in diabetics, 1982 : Nov., 1347 in dogs, j3-very low density Iipoproteins amI. 1982 in familial dyshetalipoproteinemia, 1982 : March, 450-451 in hyperlipidemia, 1982 : March, 331 LDL stimulation of cell growth and, 1982 March,397 low density Iipoproteins and, 1982 : March, 395-396 macrophage accumulation hypothesis, 1982 : March, 396-397 pathogenetic models, 1982 : March, 377 plasma triglycerides and, 1982 : March, 519-522 Athlete's foot, 1982 : July, 878 Atopic disorders, immunotherapy of, 1981 Sept., 987-1012 adverse reactions to, 1981: Sept., 1002 selecting patients for, 1981: Sept., 998-1000 Autoimmune disorder(s). See also specific disorders, as Myasthenia gravis. diahetes and, 1.982: Nov., 1215 -1217 renal tubular acidosis and, 1983 : July, 872 Autosensitization, immunodeficiency and, 1981 : Sept., 960 Azlocillin, 1982 : Jan., 61-73 Azotemia, prerenal, 1981 : ~larch, 414 BACAMPICILLIN, 1983 : Jan., 64--65 Bacillus Calmette-Guerin, prostaglandins and, 1981 : July, 836 Bacillus cereus, enterotoxigenic, 1982 Bacteriuria, asymptomatic, 1983 : Jan., 195 in aged, 1983 : March, 284--285, 452-453 Balantidium coli infection, treatment, 1982 : May, 713 Balloon tamponade, for variceal bleeding, 1983 : Nov., 1220 Barbiturates, overdose, management of, 1983 : Nov., 1288 Pco, and, in regulation of pH, 1983: July, 800 in respiratory alkalosis, 1983: July, 917-922 renal reabsorption of, 1981: March, 334; : July, 753-768, 846-847 in metabolic alkalosis, 1983 : July,905-906 in renal failure, 1983 : July, 849-850 in renal tubular acidosis, 1983 : July, 860-862 nephron sites of, 1983 : July, 763--767 serum, in mixed acid-base disorders, 1981 : March, 352-355 Bicarbonate buffer system, 1983 : July, 773 Bicarbonate-chloride exchange mechanisms, 1983 : July, 762-763 Bicarbonate therapy, alkalosis and, 1983 : July, 910-911 in ketoacidosis, 1983 : Nov., 1194 --119.5 in lactic acidosis, 1983 : July, 825-827 Biguanides, lactic acidosis and, 1983 : July, 822-823 Bile-acid binding resins, for hypercholesterolemia, 1982 : March, 540-542 Biliary tract, disorders, in aged, 1983 : March, 436 infections, cephalosporins for, 1982 See also under specific organ or procedure. of brain, in herpes sinlplex encephalitis, 1983 : Sept., 998--1001 Bithionol, for parasitic infections, 1982 : Jan., 250 Bladder, bacteriuria of, antinlicrobials for, 1982 : Jan., 206 neurogenic, in aged, 1983 : March, 457-458 Blastomycosis, South American, 1982 : Nlay, 680--683 Bleeding. See Hernorrhage . Blepharitis, 1983 trol, 1982 : Nov., 1255 --1260 control, during pregnancy, fetal nlalformations and, 1982 : Nov., 1333 -133.5 during surgery, 1982 : Nov., 1361 -1372 glycosylated henloglobin and, 1982 : Nov., 1309 -1315 measurements, in diagnosis of diabetes, 1982 -1200 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 self-monitoring of, 1982 : Nov., 1227 -1250 , 1259 -1260 in patient education, 1982 : Nov., 1302 -1303 target levels, in diabetics, 1982 : March, 256-259 Body eight, diabetes and, 1982 : Nov., 1196 Bone, buffering by, 1983 : July, 777-778 disease, in aged, 1983 : March, 356, 517-524 infections, cephalosporins for, 1982 : Jan., 186-188 loss, age-related, 1983 : March, 518 nutritional status and, 1983 : March, 301-303 skeletal, age-related changes, 1983 : March, 517-518 Bone resorption, prostaglandins and, 1981 : July, 846 Botulisnl, 1981 : Jan., 198 Bowel. See also Intestine(s). disorders, in aged, 1983 : March, 436 nl0tility, 1981 : Nov., 1377 -1396 inflanllnatory disease, in aged, 1983 March, 442-443 irritable, syndrome of, 1981: :'\'., 1386 -1:391 behavioral therapy, 1981 : Nov. , 1402 -1404 obstruction of, in aged, 1983 : March, 437-438 Bowen's disease, in aged, 1983 : March, 539 Brain, traulna to, 1981 : Jan., 20 tumors, 1981 : Jan., 21-25 viral infection of, 1983 : Sept., 991-100B reast, cancer of, RNA viruses and, 1983 : Sept., 1110 Ventilation. disordered, in aged, 1983 Ventilation. disordered, in aged, : rvlarch, 422-42.5 intennittent positive-pressure, 1983 Biliary tract, disorders, in aged, 1983 : March,436 infections, cephalosporins for, 1982 See also under specific organ or procedure. of brain, in herpes simplex encephalitis, 1983 : Sept., 998-1001 Bithionol, for parasitic infections, 1982 : Jan., 250 Bladder, bacteriuria of, antimicrobials for, 1982 : Jan., 206 neurogenic, in aged, 1983 : March, 457-458 Blastomycosis, South American, 1982 trol, 1982 : Nov., 1255 -1260 control, during pregnancy, fetal malformations and, 1982 : Nov., 1333 -133.5 during surgery, 1982 : Nov., 1361 -1372 glycosylated hemoglobin and, 1982 : Nov., 1309 -1315 measurements, in diagnosis of diabetes, 1982 -1200 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 self-monitoring of, 1982 : Nov., 1227 -1250 , 1259 -1260 in patient education, 1982 : Nov., 1302 -1303 target levels, in diabetics, 1982 : March, 256-259 Body weight, diabetes and, 1982 : Nov., 1196 Bone, buffering by, 1983 : July, 777-778 disease, in aged, 1983 : March, 356, 517-524 infections, cephalosporins for, 1982 : Jan., 186-188 loss, age-related, 1983 : March, 518 nutritional status and, 1983 : March, 301-303 skeletal, age-related changes, 1983 : March, 517-518 Bone resorption, prostaglandins and, 1981 : July, 846 Botulism, 1981 Bowe I. See also I ntestine ( s). disorders, ill aged, 1983 : March, 436 motility, 1981 : Nov., 1377 -1396 inflammatorv disease, in aged. 1983 March, 442-443 irritable, syndrome of, 1981: \'m., 1386 -1:391 hehavioral therapy, 1981 : Nov., 1402 -1404 obstruction of, in aged, 1983 : March, 437-438 Bowcn's disease, in aged, 1983 : March, 539 Brain, trauma to, 1981 : Jan., 20 tumors, 1981 -1283 control of, during surgery, 1982 : Nov., 1361 -1372 with insulin, 1982 : Nov., 1251 -1267 diagnosis of, 1982 : Nov., 1197 -1205 gestational, 1982 : Nov., 1194 , 1326 -1329 glycosylated hellloglobin and, 1982 : Nov., 1309 -1315 hyperlipidemia with, 1982 : Nov., 1347 -1360 diet therapy for, 1982 : March, 503-504 hyperosnl0lar nonketotic, 1983 : Nov., 1198 : Nov., 1373 -1388 insulin requiring, nlultiple subcutaneous insulin injections in, 1982: Nov., 1251-1267 lactic acidosis and, 1983: July, 821 male sexual dysfunction in, 1982: Nov., 1389-1396 nlaturity onset of youth, 1982 : Nov., 1197 nleticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 1329---1333 neuropathy : Jan., 195 patient education in, 1982 : Nov., 1293 -1307 pregnancy and, nlanagement of~1982: Nov., 1325 -1346 : July, 759-771 psychological aspects of, 1982 : Nov. , 1285 -1292 self-monitoring of blood glucose in, 1982 : Nov., 1227 -1250 symposium on, 1982 : Nov., 1191 -1396 Diabetic gastroparesis, 1981 : Nov., 1279 1983: July, 831-843; : Nov., 1193 -1198 Diabetic retinopathy, effect of punlp therapy on, 1982 : Nov., 1279 ---1280 Diagnostic virology, 1983 : Sept., 935-951 rapid. 19R3: Sept., 953-972 Diah'sis, hicarbonate-buffered, in lactic aci-'dosis, 1983 : July, 826-827 in acute tubular necrosis, 1981 : Jan., 160 peritoneal, in psoriasis, 1982 : May, 788 renal, pruritus in, 1982 : Sept., 1127 -1128 Diarrhea, 1981 Diabetes mellitus (Collfilllll'd) concomitant : NO\'" 1194 continuous insulin infusion in, 1982 : \lov" 1269 -1283 control of, during surgery, 1982 : Nov" 1361 -1372 with insulin, 1982 : Nov" 1251 -1267 diagnosis of, 1982 : Nov" 1197 -1205 gestational, 1982 : Nov" 1194 , 1326 --1329 glycosylated hemoglobin and, 1982 : Nov" 1309 -1315 hyperlipidemia with, 1982 : No\'" 1347 -1360 diet therapy for, 1982 : l\larch, 503-504 hyperosmolar nonketotic, 1983 : Nov" 1198 : Nov" 1373 -1388 insulin requiring, multiple subcutaneous insulin injections in, 1982: Nov" 1251-1267 lactic acidosis and, 1983: July, 821 male sexual dysfunction in, 1982: NO\ 1389-1396 maturity onset of youth, 1982 : Nov" 1197 meticulous control of, 1982 : NO\ 1317 -1324 during pregnancy, 1982 : \lo\', 1329 --1333 neuropathy of, 1981 : Jan" 195 patient education in, 1982 : No\'" 1293 -1307 pregnancy and, management of, 1982 --1346 : July, 759-771 psychological aspects of, 1982 1285--1292 self-monitoring of blood glucose in, 1982: Nov" 1227-1250 symposium : Nov" 1191 -1396 Diabetic gastroparesis, 1981 : Nov" 1279 : July, 831-843: 1983 : May, 663 in aged, 1983 : March, 28~287 antidiarrheal, 1983 : Jan., 211-213 antihypertensive, in diabetics, 1982 : Nov., 1379 antinlicrobial, outpatient use, 1983 Jan., [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . See also specific drug, as Penicillin. side effects : Jan., 113-129 antiviral, 1982 : Sept., 1111 -1113 : Sept., 1163 -1172 in chlamydial infections, 1983 : May, 663 in aged, 1983 : March, 285-287 antidiarrheal, 1983 : Jan., 211-213 antihypertensive, in diabetics, 1982 : Nov., 1379 antimicrobial, outpatient use, 1983 Jan., 3--16,57-98 . See also specific drug, as Penicillin. side effects : Jan., 113--129 antiviral, 1982 : Sept., 1111 -1113 : Sept., 1163 --1172 in chlamydial inh,ctions, 1983 azo, urticaria and, 1982 : July, 83.5 Dysbetalipoproteinelllia, fanlilial, 1982 : March, 441-452 Dysentery, amoebic, treahnent, 1982 : May, 708-709 bacillary, 1982 : May, 623-638 in intestinal mnoebiasis, 1982 : May, 692-693 Dyskinesia, tardive, with neuroleptics, 1982 Dysnlenorrhea, prostaglandins and, 1981 : July, 930 Dysphagia, in aged, 1983 : March, 349, 433-434 oropharyngeal, 1981 : Nov., 11.59-1167 Dyspnea, in aged, 1983 in terminally ill of insulin, 1982 : Nov., 1322 toxic, 1981 : Jan., 23, 28-31 Endocarditis, infectious, in aged, 1983 : March, 282-284 prophylaxis, 1983 : Jan., 106--108 rifampin for, 1982 : Jan., 160 Endocrine disorders, autoiIllmune, diabetes and, 1982 : Nov., 1215 -1217 critical, 1983 : Nov., 1193 -1213 : March, 481-495 Endophthalmitis, bacterial, 1983 : Jan., 149 Endoscopy, in gastrointestinal bleeding, 1983 azo, urticaria and, 1982 : July, 8:35 Dysbetalipoproteinemia, familial, 1982 : March, 441-452 Dysentery, amoebic, treatment, 1982 : May, 708--709 bacillarv 1982 in intes'tlnal amocbi~sis, 1982: ~1ay, 692-69:3 Dyskinesia, tardive, with neuroleptics, 1982 Dysmenorrhea, prostaglandins and, 1981 : July, 9:30 Dysphagia, in aged, 1983 : March, :349, 4:33-4:34 oropharyngeal, 1981 : Nov., 1159 --1167 Dyspnea, in aged, 1983 in terminally ill, March, 282-284 prophylaxis, 1983: Jan., 106-108 rifampin for, 1982: Jan., 160 Endocrine disorders, autoimmune, : Nov., 1215 -1217 critical, 1983 : Nov., 1193 -1213 : ~Iarch, 481-495 Endophthalmitis, bacterial, 1983 : Jan., 149 Endoscopy, in gastrointestinal bleeding, 1983 -1268 gastrointestinal hornlones and, 1981 : Nov., 1112 -1115 : July, 774 radiographic evaluation, 1981 : Nov., 1173 -1194 Esophageal scintigraphy, 1981 : Nov., 1293 --1297 Esophageal spasn1, diffuse, 1981 : Nov., 1247 -1250 behavioral therapy for, 1981 : Nov. , 1401 : Nov., 1219 -1222 Esophagus, cancer of, in aged, 1983 : March, 440 disorders, chest pain fron1, 1981 : Jan., 61 in aged, 1983 : March, 433-434 Estriol, measurement of, in diabetic pregnancy, 1982 : Nov., 1337 -1341 Estrogen therapy, in acne, 1982 : July, 861-862 in osteoporosis, 1983 : Mar., 489-490 Ethacrynic acid, 1981 : March, 293 EthaIllbutol, 1982 : Jan., 82-83 Ethanol, lactic acidosis and, 1983 : July, 759-771 hyperkalemia and, 1981 .'~1arch, 37,5 serun1, hypertonic syndron1es and, 1981 : March, 281-284 tolerance, 1981 : July, 76,5 Glucose-6-phosphate dehydrogenase deficiency, lactic acidosis and, 1983 .' July, 824 Glucose tolerance test, oral, 1982 : Nov., 1200 -1204 Glycoslyated heI11oglobin, in diabetes I11ellitus, 1982 : Nov., 1309 -1315 levels, effect of pun1p therapy on, 1982 .' Nov., 1278 in diagnosis of diabetes, 1982 : Nov., 1204 Goecken11an's regin1en, in psoriasis, 1982 .' July, 782 Goiter, nodular, in aged, 1983 .' Nlarch, 508-0510 Gonad(s), disorders, in aged, 1983 : March, 488-492 Gonorrhea, 1982 : Jan., 240-242, 248 Gout, 1981 : March, 404 acute, 1981 : Jan., 179 Granulocytopenia, as drug reaction, 1981 Granulon1a inguinale, 1982 : July, 921-922 Granulon1a, trichophytic, 1982 .' July, 880--881 GranuloI11atosis, allergic, 1982 : July, 949-951 Wegener's, 1982 : July, 948-949 Granulomatous disease, chronic, 1981 : Sept., 968 Gray syndron1e, due to chloran1phenicol, 1982 .' Jan., 97-98 Griseofulvin, 1983 : Jan., 78-79 in fungal infections, 1982 : July, 888-889 Guillain-Barre syndron1e, 1981 HDL. See High density lipoproteins (HDL) . Health, models, in patient education, 1982: Nov., 1293-1307 Heart. See also Cardiac. arrhythmias. See Arrhytll1nia(s , 198.3.' March, 42.5 in aged, 198.3: .'vlarch, 433-444 in rcspiratory alkalosis, 198.3: July, 919 infections, 1983 : Jan., 20:3-220 inflammatory disease of. See I nfiu1Il1llatory bowel disease. motility disorders of (symposium), 1981 : Nov., 1109 -1141 behavioral approaches to, 1981 : Nov., 1397 -1411 neural regnlation of motility, 1981 : Nov., 1129 -1147 sleep physiology and, 1981 . Nov., 1:359-1376 '110\., 1227 -1228 Genetic aspects, of diabetes, 1982 : Nov., 1210 -1212 , 1220 -1222 Genital herpes infections, in men, 198.3: Jan., 243-244 in women, 198.3: Jan., 226--228 Genital infection(s), viral, 198.3: Scpt., 1059 -1073 in homosexual men, 198.3: Sept., 1097 Genital ulcers, 1983 : Scpt., 1064 -106.5 Genitourinary tract, disorders, in aged, 198.3: March, 445--461 Geriatric medicine, clinical (symposium), 198.3: March, 263-543 Gestational diabetes, 1982 : Nov., 1194 -119.5, 1326 --1329 Giardiasis, in immunocompromised patient, 1982 : Mav, 749 metronidazole for, 1982 : Jan., 124 treatment, 1982 Gilles de la Tourette's syndrome, neuroleptics tor, 1.982: Sept., 100.5 Gland(s). See under specific type, as Pituitary. Glomerular fimction, acute tubular necrosis and, 1981: Jan., 1.52 indices of, 198.3: :\Iov., 1326 Glomerulonephritis, acute, 1981 : March, 416 in aged, 198.3: March, 470-472 renal failure and, 198.3: Nov., 1.327-1328 Glucagon secretjon, in diabetes mellitus, 1982 : NO\., 1317 -1319 . See also Corticosteroid(s). deficiency of, hypomineralocorticoidism and, 198.3: July, 882 excess of, 198 's regimen, in psoriasis, 1982 : July, 782 Goiter, nodular, in aged, 1983 : March, 508-510 Gonad(s), disorders, in aged, 1983 : March, 488-492 Gonorrhea, 1982 : Jan., 240-242, 248 Gout, 1.981: ~larch, 404 acute, 1981 : Jan., 179 Granulocytopenia, as drug reaction, 198I: Sept., 1098 Granuloma inguinale, 1982 : July, 921-922 Granuloma, triehophytic, 1.982: July, 880-881 Granulomatosis, allergic, 1.982: July, 949-951 Wegener's, 1982 : July, 948-949 Granulomatous disease, chronic, 1981 : Sept., 968 Gray syndrome, due to chloramphenicol, 1982 : }an., 97-98 Griseofulvin, 1983 in Helnatologic reactions, to drugs, 1981 : Jan., 121-123 Hemodynmnic Inonitoring, of critically ill, 1983 : Nov., 1343 -1360 : Jan., 69-73 Helnoglobin Ale' See Glycosylated hemoglobin. Hemolytic anemia, drug-induced, 1981 Hemoperfusion, in drug eliInination, 1983 H emophilus influenzae pneunl0nia, 1983 Hemorrhage, diverticular, in aged, 1983 March, 441-442 evaluation and managenlent : Jan., 133-146 gastrointestinal, 1983 : Nov., 1215 -1231 in acute respiratory failure, 1983 : May, 729-733 liver disease and, 1981 : Jan., 218 lower gastrointestinal, 1983 : Nov., 1225 -1228 thrombolytic therapy and, 1983 : Nov., 1186 -1187 Hemostasis, 1981 : Jan., 133 Henderson-Hasselbalch equation, 1983 : May, 647, 653 in metabolic alkalosis, 1983 : July, 809 pH and, 1983 : July, 799 Henle's loop, bicarbonate reabsorption and, 1983 : July, 755 Heparin, low-dose, in prevention of thromboemboli, 1983 : Nov., 1180 -1181 Hepatic. See also Liver. Hepatic disorders, in aged, 1983 : March, 436 Hepatic encephalopathy, 1981 : Jan., 209-226 Hepatic reactions to drugs, 1981 INDEX Hepatitis, in hOll1osexual 111en, 1983 interferon fOl, 1983 : Sept., 1155 Hepatitis B vaccine, 1983 : Sept., 1132 -1137 Hepatitis B virus, oncogenicity of, 1983 : Sept., 1119 -1121 Heroin, for pain, 1982 Herpes genitalis, in men, 1983 : Jan., 243-244 in women, 1983 : Jan., 226-228 Herpes sinlplex virus, detection of in cell culture, 1983 : Sept., 948-949 oncogenicity of, 1983 : Sept., 1112 -1115 Herpes sinlplex virus encephalitis, 1982 Sept., 991-1008 Herpes sinlplex infection : July, 807-810 drugs for, 1983 : Sept., 1164 -1167 genital, 1983 : Sept., 1059 -1064 in honlosexual nlen, 1983 in ilnmunocompronlised host, 1983 : Sept., 1082 : Sept., 974-982 Herpes simplex virus vaccine, 1983 : Sept., 1141 -1143 Herpes zoster ophthahnicus, 1983 : Sept., 982-985 Herpes zoster virus infection(s), 1982 : July, 810-812 in aged, 1983 : March, 288, 533-534 in immunocompronlised host, 1983 -1084 prevention, 1982 : Sept., 1109 -1110 : Sept., 1105 -1118 Herpetic esophagitis, in inlmunoconlpronlised patient, 1982 : May, 748 Hetacillin, 1983 : Jan., 63 Hiccough, in terminally ill, 1982 : Sept., 117.S High density lipoproteins (HDL), atherosclerosis and, 1982 : March, 331, 390 characterization, 1982 :~1arch, 403-404 clinical significance, 1982 : :Nlarch, 431-440 deficiency, with planar xanthonlatosis, 1982 : March, 479 diet-induced changes in, 1982 : March, 380-384 levels, effect of alcohol, 1982 Hemolytic anemia, drug-induced, 1981 Hemoperfusion, in drng elimination, 1983 Hemophilus injiuenzae pneumonia, 1983 Hemorrhage, diverticular, in aged, 1983 March, 441-442 evaluation and management : Jan., 133-146 gastrointestinal, 1983 : Nov., 1215 -1231 in acute respiratory failure, 1983: May, 729--733 liver : Jan., 218 lower gastrointestinal, 1983 : Nov., 1225 -1228 thrombolytic therapy and, 1983 : Nov., 1186 --1187 Hemostasis, 1981 : Jan., 133 Henderson-Hasselbalch equation, 1983 : May, 647, 653 in metabolic alkalosis, 1983 : July, 809 pH and, 1983 : July, 799 Henle's loop, bicarbonate reabsorption and, 1983 : July, 755 Heparin, low-dose, in prevention of thromboemboli, 1983 : Nov., 1180 -1181 Hepatic. See also Uver. Hepatic disorders, in aged, 1983 : March, 436 Hepatic encephalopathy, 1981 : Jan., 209-226 Hepatic reactions to drugs, 1981 I"IDEX Hepatitis, in homosexual men, 1983 interferon fo!, 1983 : Sept., 1155 Hepatitis B vaccine, 1983 : Sept., 1132 -1137 Hepatitis B virus, oncogenicity of, 1983 : Sept., 1119 --1121 Heroin, for pain, 1982 Herpes genitalis, in men, 1983 : Jan., 243-244 in women, 1983 Herpes simplex virus, detection of in cell culture, 1983: Sept., 948-949 oncogenicity of, : Sept., 1112 Herpes simplex virus encephalitis, 1982: Sept., 991-1008 Herpes simplex infection(s), 1982: July, 807-810 drugs : Sept., 1164 -1167 genital, 1983 : Sept., 1059 --1064 in homosexual men, 1983 in immunocompromised host, 1983 : Sept., 1082 : Sept., 974-982 Herpes simplex virus vaccine, 1983 : Sept., 1141 -1143 Herpes zoster ophthalmicus, 1983 982-985 Herpes zoster virus infection(s), 1982: July, 810-812 in aged, 1983 : March, 288, 533-534 in immunocompromised host, 1983 -1084 prevention, 1982 : Sept., 1109 --1110 : Sept., 1105 -1118 Herpetic esophagitis, in immunocompromised patient, 1982 : May, 748 Hetacillin, 1983 : Jan., 63 Hiccough, in terminally ill, 1982 19R2:~larch, 417-418 n1easuren1ent, 1982 :~1arch, 434-436 in clinical practice, 1982 :~1arch, 437-438 regulation, 1982 :~1arch, 403-430 Inetabolisn1, 1982 : March, 404-406 relation to very low density lipoproteins, 1982 : March, 521-522 subclasses, 1982 : March, 378-380, 433--434 with apo-E (HDLJ, origin, 1982 : March, 384-387 role in cholesterol n1etabolisn1, 1982 : March, 387-390 High-frequency ventilation, 1983 : May, 633-643 Hirschsprung's disease, 1981 : Nov. , 1380 -1382 Histalnine, in in1n1ediate hypersensitivity reactions, 1981 : Sept., 951 Histan1ine releasing agents, urticaria and, 1982 : July, 834 Histoplasmosis, 1982 Hives. See Urticaria. HLA antigens, diabetes and, 1982 -1196 , 1210 -1212 diabetic complications and, 1982 : Nov., 1217 -1218 : July, 833 RNA viruses and, 1983 : Sept., 1111 Homeostasis, n1echanisms of, 1981 : March, 284-286 Homosexual n1en, venereal disease in, 1983 -1104 Honeylnoon state, of insulin therapy, 1982 : Nov., 1239 Hookworm infection, 1982 : May, 731-742 Hordeolun1, 1983 : Jan., 222 Hydroxyurea, in psoriasis, 1982 : July, 787 Hymenolipiasis, 1982 : May, 739 Hymenoptera venon1, in ilnmunotherapy, 1981 : Sept., 996, 1002 Hyperaldosteronism, 1983 : July, 890-898 alkalosis and, 1983 : July, 912 secondary, 1983 : July, 895-898 Hyperalin1entation, parenteral, lactic acidosis and, 1983 : July, 823 Hyperbicarbonatelnia, 1981 : March, 333 Hypercalcemia, 1981 : March, 386-389 of cancer, prostaglandins and, 1981 : July, 845-853 Hypercalcemic crisis, 1983 : Nov., 1206 -1209 Hypercalciuria, renal tubular acidosis and, 1983 : July, 872-873 Hypercapnia, 1983 . See also Acidosis, respiratory. alkalosis and, 1983 : July, 911-912 chronic, 1983 417-418 measurement, 1982 : ~Iarch, 434-436 in clinical practice, 1982 : March, 437-438 regulation, 1982 : .March, 403-430 metabolism, 1982 : ~1arch, 404-406 relation to very low density lipoproteins, 1982 : March, ,521-522 subclasses, 1982 : March, 378-380, 433--434 with apo-E (HDLJ, origin, 1982 : March, 384-387 role in cholesterol metabolism, 1982 : March, 387-390 High-frequency ventilation, 1983 : May, 633-643 Hirschsprung's disease, 1981 : Nov., 138(}-l382 Histamine, in immediate hypersensitivity reactions, 1981 : Sept., 9,51 Histamine releasing agents, urticaria and, 1982 : July, 834 Histoplasmosis, 1982 Hives. See Urticaria. HLA antigens, diabetes and, 1982 -1196 , 1210 -1212 diabetic complications and, 1982 : .\10\ 1217 -1218 : July, 833 RNA viruses and, 1983 : Sept., 1111 Homeostasis, mechanisms of, 1981 : March, 284-286 Homosexual men, venereal disease in, 1983 -1104 Honeymoon state, of insulin therapy, 1982 : Nov., 1239 Hookworm infection, 1982 : May, 731-742 Hordeolum, 1983 : Jan., 13,5 Hormonal therapy, for central diabetes insipidus, 1981 . Sce also specific hormones. adrenocortical. See C orticosteroid( s). age-related changes, 1983 : ~arch, 481-495 gastrointestinal, migrating motor complex and, 1981 : Nov., 1318 -1319 : Nov., 1111 -1127 Host, de/ense, in cancer, prostaglandins and, 1981 : July, 829-844 f'lCtors, in obstructive pulmonary diseases, 1981 : May, 455--456 Human papilloma virus infection(s), 1982 : July, IH2-814 Humidification, in high-frequency ventilation, 1983 : ~1ay, 637 in mechanical ventilation, 1983 : May, 601-613 IIlllnoral immunity, assessment of, 1981 Sept., 974 Humoral mediator(s), of septic lung injury, 1983 : Mav, 703--708 Huntington's disease, in aged, 1983 : March, 356 neuroleptics for, 1982 Hydrochloric acid, in metabolic alkalosis, 1983 : May, 653--654 Hydrochlorothiazide, 1981 : March, 294, 317 Hydrogen ion, secretion, aldosterone and, 1983 : July, 880-881 in urinary acidification, 1983 : July, 753--768 Hydromorphone, for pain, 1982 11-I3-Hydroxyhse deficiency, 1983 : July. 893 17-a-Hydroxylase deficiency, 1983 Hydroxystilbamidine isethionate, f()f : Jan., 222 Hydroxyurea, in psoriasis, 1982 : July, 787 Hymenolipiasis, 1982 : May, 739 Hymenoptera venom, in immunotherapy, 1981 : Sept., 996, 1002 Hyperaldosteronism, 1983 : July, 890-898 alkalosis and, 1983 : July, 912 secondary, 1983 : July, 895-898 Hyperalimentation, parenteral, lactic acidosis and, 1983 : July, 823 Hyperbicarbonalemia, 1981 : March, 333 Hypercalcemia, 1981 : March, 386-:389 of cancer, prostaglandins and, 1981 : July, 84!Hl53 Hypercaicemic crisis, 1983 : Nov., 1206 -1209 Hypercaiciuria, renal tubular acidosis and, 1983 . July, 872-873 Hypercapnia, 1983 . See also Acidosis, respiratory. alkalosis and, 1983 : July, 911-912 chronic, 198.3: May, 648-649 H ypercholesterolemia, abnormalities of cholesterol transport in, 1982 : March, 371 differential diagnosis, 1982 : March, 539--540 familial, cholesterol synthetic rates, 1982 : March, 354-355 diet therapy for, 1982 : Match, 540 drug therapy for, 1982 : March, .540-.546 homozygous, 1982 Hypercholesterolelnia, f~1l11ilial, honlozygotes ith (Continued) nlechanisn1s for high plasnla LDL levels, 1982 :~larch, 346-3.51 therapy, 1982 : March, 3.58, .546 low density lipoprotein receptor defect in, 1982 :~larch, 335-362 pathogenesis at cellular level, 1982 : March, 338-341 pathogenesis at whole body level, 1982 : March, 341-343 surgery for, 1982 : March, .546 treatn1ent, 1982 : March, 3.55-3.58, 537-550 in diabetics, 1982 Hypercortisolisnl. See Cushing's disease. Hypereosinophilic syndronle, 1981 Hyperglycenlia. See also Diabetes lnellitus. consequences of, 1982 : Nov., 1319 hypertonic syndroInes and, 1981 :~larch, 281-284 Hyperkalenlia, 1981 July, 803 eIl1ergency treatnlent : Jan., 165-176 hyperchloren1ic Inetabolic acidosis and, 1983 : July, 789--790 hypoaldosteronisnl and, 1983 : July, 881-890 in hypertensive diabetics, 1982 : Nov., 137H in renal failure, 1983 : Nov., 1337 -1338 in renal tubular acidosis, 1983 : July, 874-876 in renal tubular necrosis, 1981 :~larch, 424 Hyperkeratosis, subungual, in psoriasis, 1982 : July, 773 Hyperlactacidenlia, 1983 : July, 815-829 Hyperlipiden1ia(s), approach to patient, 1982 : March, 319-333 athersclerosis in, 1982 : March, 331 diet therapy for, 1982 : March, 485-518 faIl1ilial dysbetalipoproteinen1ia and, 1982 : March, 448-4.50 hypertension with, salt restriction for, 1982 : March, .51:1-.51.5 in children, diet therapy for, 1982 : March, .504 of pregnancy, diet therapy for, 1982 : March, .504-.50.5 single diet concept for, 1982 :~1arch, 499--502 therapeutic decision-lnaking, 1982 : larch, 331-332 with diabetes, 1982 : Nov., 1347 -1360 diet therapy for, 1982 : March, .503-.50.f xanthon1as in, 1982 : March, 330-331 Hyperlipoproteinenlia, atherogenic, 1982 : March, 375-402 with diabetes, 1982 -13.51 INDEX Hypennineralcorticoidisn1, in Inetabolic alkalosis, 1983 : July, 907-908 H ypernatrelnia, hypertonic syndn)Jnes and, 1981 :~larch, 271-281 Hyperosnl0lality, 1981 :~larch, 272 in ketoacidosis, 1983 : July, 837 Hyperosnlolar nonketotic con1a, 1983 : Nov., 1198 Hyperparathyroidisn1, 1981 : March, 387 Hyperphosphaten1ia, 1981 : March, 391, 396-398 in chronic renal failure, 1981 : March, 442 Hyperplasia, nodular lynlphoid, 1982 .5 Hypersensitivity, arachidonic acid nletabolites as nlediators : July, 809-828 inlmediate, iInnlune n1echanisnls in, 1,981: Sept., 941-957 nlediators of, 1981 : Sept., 9.51-9.5.5 Hypersensitivity reactions, to penicillin, . 1983 : Jan., 114-121 Hypertension, hyperlipidelnia with, salt restriction for, 1982 : March, .513-.51.5 in aged, 1983 : March, 395-417 in diabetics, 1982 : Nov., 1373 -1388 : July, 906 puhnonary artery, in obstructive lung disease, 1981 : May, 489--49.5, .5.54 systolic, in diabet'ics, 1982 : Nov., 1378 -1379 Hyperthernlia, in overdose patient, 1983 -1283 Hyperthyroid crisis, 1983 : Nov., 1202 -1203 Hyperthyroidisnl, in aged, 1983 : March, 499--.503 nlyopathy of, 1981 : Jan., 197 Hypertonicity, hypernatren1ia and, 1981 : larch, 271-281 . potassiunl balance and, 1981 :~larch, 36.5 treahnent of, 1981 : lvlarch, 286-288 Hypertriglyceridelnia, 1982 : lvlarch, 519-535 in diabetics, 1982 -13.51 Inechanisn1s, 1982 : lvlarch, .522-.527 Hyperuricenlia, 1981 : March, 299, 403-409 Hypoadrenocorticisn1, 1983 : Nov., 1205 -1206 Hypoaldosteronisnl, 1981 : July, 881-890 H ypoalphalipoproteinelnia, fan1ilial, 1982 : March, 478 Hypobetalipoproteinenlia, f::lInilial, 1982 : March, 472-473 with chyloInicronelnia, 1982 : March, 474 Hypocalcelnia, 1981 : March, 389-392 Hypocalcen1ic crisis, 1983 : Nov., 1209 --1210 lI~vocapnia, 1983 levels, 1982 levels, . March, :346-3.51 therapy, 1982 levels, : 'vlarch, :358, 546 low density lipoprotein receptor defect in, 1982 levels, : 1\1 arch, 335-362 pathogenesis at cellular level, 1982 March, 338--341 pathogenesis at whole body level, 1.982: ~Iarch, 341-343 surgery hJr, 1982 : "'larch, 546 treatment, 1982 : March, :35.5--358, 537-550 in diabetics, 1982 --1351 Hypercortisolism. See Cushing's disease. Hypereosinophilic syndrome, 1981 1066 Hyperglycemia, See also Diabetes lIlellitus. consequences of~ 1982: Nov., 1:319--1320 hypertonic syndromes and, 1981 : l\larch, 281-284 Hyperkalemia, 1981 July, 803 emergency treatment : Jan., 165-176 hyperchloremic metabolic acidosis and, 1983 : July, 789--790 hypoaldosteronism and, 1983 : July, 881-890 in hypertensive diabetics, 1982 : ]\io\,., 1371 in renal failure, 1983: ]\io\,., 1337 -1338 in renal tubular acidosis, 1983 : July, 874-876 in renal tubular necrosis, 1981 : March, 42.J Hyperkeratosis, suhungual, in psoriasis, 1982 : July, 773 lIyperiactacidemia, 1983 : July, 815-829 Hvperlipidemia(s), approach to patient, 1982 : March, 319-333 athersclerosis in, 1982 : 'vlarch, 331 diet therapy lor, 1982 : March, 485-518 Elmilial dysbetalipoproteinemia and, 1982 March, 448--450 hypertension with, salt restriction 1 (", : March, 51:1-515 in children, diet therapy for, 1982 March, 504 of pregnanc)" diet therapy for, 1982: March, .504-.505 single diet concept : l\larch, 499--502 therapeutic decision-making, 1982 : March, 331-332 with diabetes, 1982 : Nov., 1347 -1360 diet therapy lor, 1982 : March, .S03-50.J xanthomas in, 1982 : l\larch, 330-3.31 Hyperlipoproteinemia, atherogenic, 1982 March : "larch, 513-515 in aged, 1983 : March, 395-417 in diabetics, 1982 : Nov., 1373 -1388 .July, 906 pulmonarv artery, in obstructive lung . Mav, 489--49.5, 554 systolic, in diabetics, 1982 : No\'., 1378 -1379 Hyperthermia, in overdose patient, 1.983: Nov., 1282 -1283 Hyperthyroid crisis, 1983 . Nov., 1202 -1203 Hyperthyroidism, in aged, 1.983: March, 499--503 myopathy of, 1981 : Jan., 197 Hypertonicity, hypernatremia and, 1.981: March, 271-281 potassium balance and, 1981 : ~Iarch, .'365 treatment of 1981 : March, 286-288 Hypertriglyceridemia, 1982 : March, 519-535 in diabetics, 1982 --13.51 mechanisms, 1982 : l\larch, .522-527 Hyperuricemia, 1.981: March, 299, 403-409 H ypoadrenocorticism, 1983 : No\,., 120.5--1206 Hypoaldosteronism, 1981 . July, 881-890 lIypoalphalipoproteinemia, lamilial, 1982 March Hypochlorhydria, bacterial overgro th and, 1982 :~1ay, .563 Hypocortisolisnl, 1983 : Nov., 120.t':r-1206 Hypoganlnlaglobulinenlia, COnl1110n variable acquired, 1982 :~Iay, 74.5 X-linked infantile congenital, 1982 : May, 74.5 Hypoglycenlia, exercise-induced, 1982 : Nov., 1246 : March, 486--487 prevention of, 1982 : Nov., 1261 -1262 ith continuous delivery of insulin, 1982: Nov., 1280--1281 Hypoglycelnic agents. See Insulin. Hypoglycemic coma, 1983 -1202 Hypokalenlia, 1981 : July, 803 hyperaldosteronisnl and, 1983 : N1ay, 73.5 orthostatic, "in aged, 1983 : NIarch, 386-387, 404 in diabetics, 1982 : Nov., 1379 with tricyclic antidepressants, 1982 -1042 Hypothernlia, in aged, 1983 : NIarch, 336 Hypothyroid crisis, 1983 : Nov., 1203 -120.5 Hypothyroidisnl, hyponatrelnia ith, 1981 : NI arch, 267 in aged, 1983 :~larch, .503-.508 Hypotonic hyponatrelnia, 1981 : Nlarch, 267 Hypouricenlia, 1981 : March, 409 Hypoventilation, alveolar, 1983 : Jan., 189 in aged, 1983 : March, 427-429 prophylaxis, 1983 : Jan., 103-106 infiltrates with eosinophilia, 1981 : Sept., 1059 -1069 injury, in ARDS, 1983 : May, 689-690 prostaglandin metabolism in, 1981 : July, 789-808 secretions, in smokers, 1981 March, 264 in airways of smokers, 1981 : May, 673 Lymphogranuloma venereUln, 1982 : Sept., 106S--1067 Lymphoma, cutaneous T cell, : July, 895-913 viruses and, 1983 : Sept., 1110 , 1115 -1117 Lymphoproliferative disorders, 1981 : Sept., 970 McARDLE's syndrome, 1981 : Jan., 205 Macrodantin. See Nitrofurantoin. Macrophage, pulmonary, in sn10kers, 1981 : May, 668, 679 Magnesium, deficiency, in Bartter's syndrome, 1983 : July, 896 Magnesium balance, in chronic renal failure, 1981 : March, 437 Majocchi's granuloma, 1982 : July, 880-881 Malaria, prophylaxis, 1983 Malignant disease. See also Carcinoma. hematologic, disorders of phagocytosis with, 1981: Sept., 968 immunodeficiency and, 1981: Sept., 960 Malnutrition, imn1unodeficiency and, 1981: Sept., 970 protein-calorie, in acute respiratory failure, 1983 : May, 739 with hypolipidemia, 1982 : March, 479-480 Mannitol, 1981 Mast cell(s), in asthma, 1981: Sept., 1015-1018 in immediate hypersensitivity reactions, 1981: Sept., 94S--950 Nutritional status, asseSSlnent of: in critically ill, 1983 : Nov., 1297 , 1338 infection and, 1983 : Nov., 1297 Inaintenance of, in acute respiratory hlilure, 1983 : Mav, 739-741 respiratory Inus~le fatigue and, 1983 lay, 581-582 Nutritional support, excessive, in critically ill, 1983 : Nov., 1301 -1302 1110nitoring of, in critically ill, 1983 : Nov., 1300 -1302 OBESITY, diabetes and, 1982 asthma chronic bronchitis and emphysema, 1983: I\lay, 661-663 in hospitalized asthmatics May, 456 in chronic obstructive lung disease Bruton's syndrome Buffer systems Burkitt's lymphoma, Epstein-Barr virus and severe 50 metabolism Calicivirus infection(s), gastroenteric Caloric balance, positive. See Obesity. Calories, efIect on lipid metabolism Sept., 1156--1157 viruses and Candida albicans, in fungal enteritis 230 chronic mucocutaneous, 1.981: Sept., 966 treatment of~ 1.982: July Carbohydrates, dietary, effect on high density lipoprotein levels IIlEX Carbon dioxide, bicarbonate bufier svstem and, 1.983: July, 773 . excretion, by lung Carbonic acid, bicarbonate hufier system and host defense in, prostaglandins and, 1981: J Illy, 829-844 hypercalcemia of, prostaglandins and March, 510-512 pain, morphine for See Arrhythmia(s), and specific types. Cardiac care, acute Cardiac output, decrease of, from end-expiratory pressure, 1983: .'vI ay Cardiovascular complications, of acute respiratory failure, 1.983: May Cardiovascular function, efiect of mechanical ventilation on Cardiovascular performance, in obstructive lung disease Cardiovascular system, disorders, in aged, 1.983: March, 379-394 . in elderly hypertensives, 1.983: March Catecholamine(s), potassium balance and Cathartic(sl, for constipation, 1.982: Scpt Catheter(s), technical considerations of Catheterization, infection and, 1.983: Jan., 198-199 pulmonary artery, complications of respiratory bilure, complications of, 1.983: ~Iay, 728 1983: Sept., 1114-1115 papillonlavirus and Charcoal, activated, in drug elimination See also specific agents and disorders. for warts radiographic examination of, in critical care medicine Cheyne-Stokes respiration Child(ren), asthma in Chlamydia infection(s), genital Chlalnydia pneumonia in metabolic alkalosis Chloride-bicarbonate exchange mechanisms Chloroquine phosphate, for intestinal protozoan infections Cholecystogastric scintigraphy March, 387-390 net transport, relation to cholesteryl ester transfer INDEX Catheterization (Continued) systemic arterial, complications of diagnostic virology Cellular immunity, assessment of Cellular mediator(s), of septic lung injury Central nervous system. Sec Nervous system, central. Cephalexin Cephalosporin(s), first and second generation 28-31 third generation Cerebellar ataxia, progressive Cerebral edema, diabetic ketoacidosis and Cerebrovascular disease Cervical secretions, laboratory examination Sept., 1114-1115 papillomavirns and Charcoal, activated, in drug elimination See also specific agents and disorders. for warts radiographic examination of, in critical care medicine Cheyne-Stokes respiration Child(ren), asthma in, 1.981: Sept., 1040 gastrointestinal bleeding in, 1.983: :'IIov 1228 ., hyperlipidemia in, diet therapy for, 1.982: March, 504 immunization of, 1.983: Jan Chlamydia infection(s), genital, 1.983: Sept., 106.5-1069 ocular Chlamydia pneumonia, 1.983: Kov in metabolic alkalosis, 1.983: July Chloride-bicarbonate exchange mechanisms Chloroquine, for parasitic infections Chloroquine phosphate, for intestinal protozoan infections Cholecystogastric scintigraphy, 1.981: Nov Cholesterol, dietary, effect on lipid metabolism net transport, relation to cholesteryl ester transfer transport, abnormalities in hypercholesterolemia Cholesteryl ester transfer, relation to cholesterol net transport Cholinergic urticaria Chylomicron(s) familial hypobetalipoproteinemia with 69-70 disposition of in liver disease Coagulation factor(s), disorders of Colistimethate sodium. See Sodium colistimethate 1385 cancer of ulcerations, due to Yersinia infection 117-132 differential diagnosis of, 1983: Nov., 1281 hyperosmolar nonketotic See also Antimicrobial therapy, combination. Complement, in immune complex reactions, 1981: Sept., 944 in septic lung injury Computed tomography, in herpes sinlplex encephalitis Concussion Condylomata acuminata Confusion Confusional state, acute Congenital defects, fetal, diabetes and Congestive heart failure, radiographic features of 141-142 in neonates Constipation, idiopathic, 1981: Nov., 1386 in aged Contact dermatitis, allergic eczematous terminally ill Coronavirus infection(s), gastroenteric, 1983: Sept., 1047 respiratory Cor pulmonale Corpus luteum function, prostaglandins and Cholesteryl ester transfer, relation to cholesterol net transport Cholinergic urticaria Chylomicron(s) familial hypobetalipoproteinemia with liver disease Coagulation factor(s), disorders of Colistimethate sodium. See Sodium colistimethate 1385 cancer of ulcerations, due to Yersinia infection 117-132 differential diagnosis of, 1983: Nov., 1281 hyperosmolar nonketotic C ontinllcd) in surgical patients, 1982: :\Iov Combination therapy Sept., 944 in septic lung injury Computed tomography, in herpes simplex encephalitis Concussion Condylomata acuminata Confusion Confusional state, acute Congenital defects, fetal, diabetes and Congestive heart failure, radiographic features of 141-142 in neonates Constipation, idiopathic, 1981: Nov., 1386 in aged Contact dermatitis, allergic eczematous Continuous positive airway pres·sure. See IJACRYOADENITIS IJeath and dying. See Tenninal illness Dehydroelnetine dihydrochloride, for intestinal protozoan infections Sept., 1146-1147 pathophysiology of Alzheimer's type (SDAT), 1983: March, 363-364 treatment of Sept., 1148-1149 drug therapy for Sept., 1086 treatment of Dennatologic disorders Dermatologic reactions, to antibiotics See under specific disease, as Psoriasis 1191-1197 INDEX Corticosteroids (C ontinlled) in AHDS, 1983: l'vlav, 717-724 in allergic disease, 1981: Sept., 1073-1081 in chronic bronchitis and emphysema terminally ill See Ventilation, continuolls positive pressure 1295-1304 symposium on Crohn's disease, in aged Cromolyn sodium Cromone(s), for pruritus Crystal deposition, arthritis and Cushing's disease, steroid-induced Cushing's syndrome Cutaneous complications, with intravenous delivery of insulin Cutaneous T cell lymphoma, treatment of Cyclic 3'5' -monophosphate (cAMP), in immediate hypersensitivity reactions Cystic fibrosis, left ventricular perfc) children, trimethoprim-sulfamethoxazole for Cytologic examination, in diagnostic virology Cytomegalovirus infection(s), in homosexual men, 1983: Sept" 1098-1100 in immunocompromised host Cytotoxic reactions Death and dying. See Terminal illness Defecation, difficult, treatment for See SwallOWing. Dehydroemetine dihydrochloride, for intestinal protozoan infections Sept., 1146-1147 pathophysiology of Alzheimer's type (SDAT), 1983: March, 363-364 treatment of Sept., 1148-1149 drug therapy for Sept., 1086 treatment of Dermatologic disorders Dermatologic reactions, to antibiotics See under specific disease, as Psoriasis, Dermographism for pain Idiopathic diabetes Sept., 973-974, 1164 for viral infections Ilelllll , ulcerations, due to Yersinia infection Inlidazolidinyl urea, dernlatitis froln Sept., 1037-1045 for sleepwalking IInmune response, cell-Inediated, in aged Imnlune serUlll globulins, human Immune systenl, age-related changes Sept., 941-957 effect of interferon on, 1983: Sept., 1148-1149 in obstructive airway disease, 1981:~1ay, 683-685 viruses and Sept., 961 nonnal, 1981: Sept., 9.59 to viruses Sept., 970 syndronles, gastrointestinal infections and, 1982:~lay, 743-753 viral infections and Hypoglycemic agents. See Insulin. Hypoglycemic coma July, 803 hyperaldosteronism and Hypolipidemia(s), 1982: },Iarch, 469-484 diarrhea with, 1982: March, 479-480 immunoglobulin disorders with Ih'er disease with, 1982: ~Iarch, 480 malnutrition with Bm·tter's syndrome hypotonic Mav, 7:35 orthostatic 1203-120.'j Hypothyroidism, hyponatremia with Hvpotonic hyponatremia 5b Hvpoxemia, acute, in respiratory failure. 1983: Mav, .5.55 of chronic ohstructive lung disease, home oxvgpn tlwrapy for, 1981: .\Iay, 615-627 treatment IATROGENIC disease, cutaneolls Ibuprofen, as prostaglandin synthesis inhibitor Idiopathic diabetes, 1982: I\ov" 1192-1194. See also Diahetes IIlcllitus Sept., 973-974, 1164 for viral infections Ileum. ulcerations, due to Yersinia infection Imidazolidinyl urea, dermatitis from Sept., 1037-1045 for sleepwalking Immune response, cell-mediated, in aged, 198.3: ~Iarch, 268--270 -humoral Immune serum globulins, human Immune system, age-related changes Sept., 941-957 efIect of interferon on, 198.3: Sept., 1148--1149 in obstructive airway disease 59 to viruses Mav, 743-753 viral infecti;ns and virus detection Immunoglobulin(s), alterations, in obstructive lung disease in lung secretions of slnokers Sept., 978 in immediate hypersensitivity reactions obstructive lung diseases, 1'<:)61:~lay diagnostic virology Immunologic disorders, pulmonary, eosinophils and Immunologic methods, in virus detection Immunostimulation, by prostaglandin synthetase inhibitors Immunosuppressive therapy, pneumonia and Sept., 1040 in atopic disorders, 1981: Sept., 987-1012 adverse reactions to organic erectile, in male diabetics Infant(s), gastrointestinal bleeding in Infarction, cerebral. See Transient ischemic attack(s). pituitary See also Sepsis. acute respiratory failure with -715 mixed, con1bination therapy for 253-258 pulmonary. See Lung(s), infections and specific pathogens. respiratory, airway reactivity and, 1981: Sept., 1045-1053 sexually transmitted, in men Inflammation, arachidonic acid Inetabolites as mediators of prostaglandins and Influenza virus infection(s), 1983: Sept., 1012, 101&-1017 drugs for obstructive lung disease, 1981: ~Iay, 68:>-685 disorders, with hypolipidemia in lung secretions of smokers Sept., 978 in immediate hypersensitivitv reactions diagnostic virology Immunologic disorders, pulmonary, eosinophils and Immunologic methods, in virus detection Immunostimulation, by prostaglandin synthetase inhibitors Immunosuppressive therapy, pneumonia and Sept., 1040 in atopic disorders, 1981: Sept., 987-1012 adverse reactions to 57 organic erectile, in male diabetics as prostaglandin synthesis inhibitor Infant(s), gastrointestinal bleeding in See Transientischernic attack(s). pituitary 571 I:-IUEX Infection(s) (Contillul'd) catheter-associated 253-258 pulmonary. See Lung(s), infections and specific pathogens. respiratory, airway reactivity and, 1981: Sept., 1045-1053 sexually transmitted, in men symposium on, 1983: Sept., 935-1172. See also Virus(es); Viral infections. Infectious diseases, immunization against InHammation, arachidonic acid metabolites as mediators of prostaglandins and InHuenza vaccine drugs for 1235 INDEX Insect stings, anaphylactic reaction to InsOlnnia, 1.982: Sept., 972-977 in ternlinally ill, 1.982: Sept., 1177 treatnlent for, 1.982: Sept -1246 secretion, in diabetes nlellitus See also Diabetes mellitus Intensive care Intestinal secretion, prostaglandins and See also Bowel. function during sleep -438 pseudo-obstruction syndronles Intracranial tunl0rs complications of, 1983: Nlay, 729 with high-frequency ventilation Ion exchange systenl recurrent herpes infection 1386-1391 behavioral therapy Ischelnic heart disease, in aged Islet cell, destruction, in diabetic ketoacidosis See Cell culture. Isolation and susceptibility testing, for pathogens 81-82 disposition of, in liver disease inflammation. See specific disorders, as Rheulnatoid arthritis biDEX Insect stings. anaphvlactic reaction to Sept., 972-977 in tcnninallv ill, 1982: Sept., 1177 treatment for -1261 in self-monitoring of blood glucose, 1982. Nov" 1235-1246 secretion, in diabetes mellitus See also Diabetes mellitus. Insulin infusion devicc(s), portable 1214-1217 Intensive care Intestinal secretion, prostaglandins and See also Bou;el, function during sleep -438 pseudo-obstruction syndromes Intra-aortic counterpulsation, 1981: J an complications of Ion exchange system recurrent herpes infection Irritable bowel syndrome Ischemic heart disease, in aged Islet cell, destruction, in diabetic ketoacidosis Isolation, of viruses, See Cell culture, Isolation and susceptibility testing, for pathogens 81-82 disposition of, in liver disease -530 inflammation, See specific disorders, as Rheumatoid arthriti~ 238-240 cyton1egalovirus infection and Keratolytic agents disease. See also specific disorders. chronic, hyponatren1ia with -878 vascular regulation, prostaglandins and tilning of Laboratory test(ing), in acid-base disorders asseSSlnent of renal failure LacriInal apparatus, infections Lactate, metabolic regulation of Lactic acidosis Lavage, gastric, in drug elin1ination Laxative, chronic diarrhea due to, 1982: May, 605 for constipation, 1982: Sept Low density lipoproteins (LDL) Lecithin:cholesterol acyltransferase, cholesterol net transport and Lecithin: sphingomyelin ratio Leukocyte(s), aggregation, in septic lung injury Leukotriene(s), in in1lnediate hypersensitivity, 1981: Sept., 953 in septic lung injury Light eruption, polylnorphous cytomegalovirus inft'ction and Keratolytic agents 79 for fungal infections disease. See also specific disorders. chronic, hyponatremia with Mechanical ventilation. See Ventilation, nwchanical 689-690 of septic lung injury See Drug(s) or under specific n1edication Meningococcal pneumonia Meningococcal vaccine Mesenteric artery, occlusion of See Acidosis, nl,etabolic. Metabolic alkalosis. See Alkalosis, metabolic. Metabolism, disordered, in diabetes mellitus Meter(s), reflectance, for self-monitoring of blood glucose \It·th;lJlol. lactic acidosis ;llld. /()~'j Jllh. H2M ethenamine psoriasis psoriasis See also Pncwnonia(s) and specific pathogens acute respiratory failure cutaneous, treatment of, 1.982: July, 795-805 photosensitivity in Lyell's syndrome Lyme arthritis Lymphocyte(s), age-related changes Lymphogranuloma venereum, 1.982: July -913 viruses and, 1.983: Sept., lll0, lll5-1ll7 Lymphoproliferative disorders, 1.981: Sept Magnesium, deficiency, in Bartter's syndrome Magnesium balance, in chronic renal failure Majocchi's granuloma 109-ll0 Malignant disease. See also Carcinoma. hematologic, disorders of phagocytosis with acute respiratory failure, 1.983: May, 739 with hypolipidemia, 1.982: March Mast cell(s), in asthma, 1981: Sept., 1015-1018 in immediate hypersensitivity reactions Mechanical ventilation. See Vellti/ation, mechanical Mav, 689-690 of septic lung injury See Drug(s) or under specific medication rifampin for Meningococcal pneumonia Meningococcal vaccine Mesenteric artery, occlusion of See Acidosis, metaholic. Metabolic alkalosis. See Alkalosis, metabolic. Metabolism, disordered, in diabetes mellitus leter(s), reflectance, for self-monitoring of blood glucose lethicillin, resistance and tolerance to psoriasis psoriasis INDEX Nletoclopranlide, for gastroesophageal reflux 79-80 for antibiotic-associated pseudoluelubranous colitis, 1982: Mav 660-661 for giardiasis Microfilaria infestation virus detection Migrating motor complex, in sluall intestine See also Aldosterone. deficiency of Mineralocorticoid therapy Mitral stenosis Molluscum contagiosum Monitoring, self-regulated, of blood glucose Monoamine oxidase inhibitors Monoclonal antibodies, viral pharmacokinetics of, 1982: Sept., 1086-1087 pharmacology of, 1982: Sept., 1061-1071 Motor complex, migrating, in snlall intestine Motor disorders, gastrointestinal, symposium on Motor neuron disorders Mucus plugging, in asthlua Muscle(s), of respiratory tract, perfornlance of cutaneous T cell lynlphoma Myasthenia gravis Mycoplasma pneunl0nia systenlic, antiluicrobial therapy for Mycosis fungoides, treahnent of Myocardial infarction, prostaglandins and Myxovirus infection(s), in imnlunocompronlised host psoriasis, 1982: July, 773 fungal infection 75-76 for shigellosis drug elimination Narcotic drug(s), for pain, 1982: Sept., 1091-1104 in terminally ill, 1982: Sept., 1179-1182 in aged, 1982: Sept., 1079-1089 overdose, management of Nasal polyps 79-80 for antibiotic-associated pseudomembranous colitis, 1982: May, 660-661 for giardiasis Microfilaria infestation virus detection Migrating motor complex, in small intestine See also Aldosterone. deficiency of Mineralocorticoid therapy Mitral stenosis Molluscum contagiosum Monitoring, self-regulated, of blood glucose Monoamine oxidase inhibitors Monocional antibodies, viral pharmacokinetics of, 1982: Sept., 1086-1087 pharmacology of, 1982: Sept., 1061-1071 Motor complex, migrating, in small intestine Motor disorders, gastrointestinal, symposium on Motor neuron disorders Mucociliary system, in asthma Mucus plugging, in asthma Muscie(s), of respiratory tract, performance of cutaneous T celllymphoma Myasthenia gravis Mycoplasma pneumonia systemic, antimicrobial therapy for Mycosis fungoides, treatment of Myocardial infarction, prostaglandins and Myxovirus infection(s), in immunocompromised host psoriasis, 1982: July, 773 fungal infection Nalidixic acid drug elimination Sept., 1091-1104 in terminally ill, 1982: Sept., 1179-1182 in aged, 1982: Sept., 1079-1089 overdose, management of, 1983: Nov., 1289 pharmacology of, 1982: Sept., 1061-1071 relative potencies of, 1982: Sept., 106~1071 side effects of Nasal polyps Necatur anwricanU8 infection, 1982:~lay Neonate(s), chlan1ydial disease in See Carcinolna; Malignant disease; Tunwr(s); and specific disorders renal failure and -923 in respiratory alkalosis, 1983: July, 918-919 infections, cephalosporins for treatInent for Neurogenic bladder Sept., 993-1009 relative potencies of, 1982: Sept., 995 side effects of Neurologic disorders, in aged See also specific disorders. acute sexual dysfunction and gastrointestinal n10til-ity Neutrophil(s), aggregation, in septic lung injury, 1983: l 'lay, 709-710 polyn10rphonuclear 248-249 for tape\VOrn1 infections Nicotinic acid, for hypercholesterolen1ia Night terrors, 1982: Sept Sept., 1064 Nitrogen n1ustard, in cutaneous T celllyn1-phon1a Nocardia pneunl0nia Non-insulin-dependent diabetes (NIDD) Nonsteroidal anti-inHan1l11atory drugs (NSAIDs), for pain Norwalk-like virus Norwalk-like virus infection(s), gastroenteric, 1983: Sept Nosocolnial infection(s) 1110rbidity and 1110rtality of~1983: Nov., 1255-1258 prevalence of Nutrient(s), ad111inistration in critically ill acute respiratory failure 1.59 in aged, 1983:~larch, 295-313 in critically ilL Necatur alllericarl1ls iufection :331 ]\;eomycin, dermatitis from, 1981: Sept., 1084 for hepatic encephalopathy Neonate(s), chlamydial disease in See Carcinoma; II,talignant disease; Twnor(s); and specific disorders ~Iarch, 418 renal failure and in respiratory acidosis, 198.3: July, 922-923 in respiratory alkalosis treatment for Neurogenic bladder, in aged Neuroleptic drug(s), for pruritus. 1982: Sept., 1124-1125 for psychosis Neurologic disorders, in aged See also specific disorders. acute sexual dysfunction and Neutrophil(s), aggregation, in septic lung injury. 1983: ~Iay airways of smokers Nicotinic acid, for hypercholesterolemia Night terrors, 1982: Sept Sept., 1064 Nitrogen mustard, in cutaneous T celllymphoma Nocardia pneumonia Nocturnal oxygen therapy trial Non-insulin-dependent diabetes (N1DD) Nonsteroidal anti-inHammatory drugs (NSA1Ds), for pain Norwalk-like virus Norwalk-like virus infectioll(s), gastroenteric, 1983: Sept control of~ 1..983: No\'., 1259--1260, 1268--1270 morbidity and mortality of 52-125.5 risk factors of Nutrient(s), administration in critically ill psoriasis aged, 1.982: Sept 524 nutritional status and Otitis nledia trilllethoprinl-sulfalnethoxazole for Ovary, disorders, in aged critically ill Oxolinic acid acute respiratory failure supplelllental, during exercise training Oxygenation, adult respiratory distress syndrolne and arterial, ll1aintenance of, in acute respiratory failure, 1983:~lav, 61.5-616 of tis~ues, assessnlent of Oxytocin challenge test, in diabetic pregnancy :3:31) infection and, 1983: :'I/ov., 1297 maintenance of I\utritional support, excessive, in critically ill I\ov., 1196 ellect on aging lung \Iarch, 409--410 respiratory muscle btigue in See also specific diseases. acute respiratory bilure in 1:310 respiratory care f()r, 1981: May, 629-645 home oxygen in Occlusion, plastic, in psoriasis Ocular infection(s), 1.983: Jan., 131-152 chloramphenicol f()r, 1.982: Jan., 94 viral,1.983. Sept Office practice, microbiologic testing in Oncogene(s), viral, 1983: Sept psoriasis, 1.982: July Organic mental syndrome 524 nutritional status and 164-166 acute, trimethoprim-sulfamethoxazole for aged, 1.983: :\larch critically ill Oxolinic acid 54:3 therapy, home Oxygenation, adult respiratory distress syndrome and of tissues, assessment of diabetic pregnancy control, consultation service, 1982: Sept Sept., 117S-1182 with nonsteroidal anti-inflmnnlatory drugs insulin secretion Panic, as reaction to illness South American blastonlycosis due to Parainfluenza virus infection(s) Paramyxovirus infection(s), in immunoconlpromised host Parasitic infection(s), diagnosis of See also specific agent, such as Metronidazole. sexually transmitted Parkinson's disease, in aged Paromonlycin, for intestinal protozoan infections, 1982: May, 717 for tapeworm infections Pathogens, isolation and susceptibility testing for Patient selection, for continuous delivery of insulin Pavor nocturnus Pco 2 , bicarbonate and, in regulation of pH in respiratory acid-base disorders 221-226 tetracyclines for Penicillin, anaphylactic reaction to See specific agent, such as Carbenicillin See also specific agent, such as Methicillin. adverse reactions to. 1.082: Jan., 56-57 resistance to Penile prostheses, for diabetic ilnpotence Peptic ulcer disease, behavioral therapy for Peptide(s), fibrin-derived, in septic lung injury Sept., 1172-1173 with narcotics, in terminally ill, 1982: Sept., 1179-1182 with nonsteroidal anti-inflammatory drugs, 1982: Sept., 1053-1059 in aged, 1983: March, 334-335 narcotics for insulin secretion Pancreatic cholera syndrome Panic, as reaction to illness South American blastomycosis due to Parainfluenza virus infection(s), 1983. Sept Paramyxovirus infection(s), in immunocompromised host See also specific agent, such as M etronidazo/e. sexually transmitted Parkinson's disease, in aged for intestinal protozoan infections, 1982: Mav, 717 for tapeworm infe~tions Pathogens, isolation and susceptibility testing for It)r continuous delivery of insulin, 1982: Kov., 1272-1274 psychological aspects of, 1982: Ko\'. , 1286--1287 for meticulous control of diabetes Pavor nocturnus regulation of pH bicarbonate buffer system and, 1983: July, 773 elevated, alkalosis and -226 tetracyelines for, 1982: J an Penicillin, anaphylactic reaction to See specific agent, such as Carbenicillin See also specific agent. such as Methicillin. adverse reactions to. 1.%2: Jan., 56--57 resistance to Penile prostheses, for diabetic impotence Peptic ulcer disease, behavioral therapy lor Peptide(s). fibrin-derived, in septic lung injury INDEX Pericardiuln, infections, cephalosporins for Perinatal risk, nlaternal diabetes and anlnl0niagenesis and renal failure of antilnicrobial drugs See also Drug(s). phannacokinetic principles, in aged, 1982: Sept Pharyngoesophageal swallowing disorders Phencyclidine (pep), overdose, 111anage-nlent of chronic renal failure prenatal diagnosis of respiratory distress syndrome Phosphorylase deficiency cutaneous T cell lymphonla Photoprotective agent(s) psoriasis for parasitic infections Pituitary gland, disorders. See also specific disorders, as Cushing's disease Pituitary gonadotrophin secretion, prostaglandins and Placebo effects, in treatnlent of denlentia resistance to antinlicrobial therapy Platelet(s), aggregation, in septic lung injury Pneunl0coccal vaccine Pneunwcystis carinii infection(s), tri111etho-priln-sulfanlethoxazole for Pneumocystis pneunlonia See also specific pathogens. atypical, tetracyclines for acute respiratory failure Pneumothorax, radiographic features of INDEX Pericardium, infections, cephalosporins for Perinatal risk, maternal diahctes and ammoniagent'sis and renal failure of antimicrobial drugs See also Drug(sj. phannacokinetic principles, in aged, 1982: Sept 153-1.51> viral Pharyngoesophageal swallowing disorders Phencyclidine (PCP), overdose, management of chronic renal failure prenatal diagnosis of respiratory distress syndrome Phosphorylase deficiency cutaneous T cell lymphoma psoriasis \1 ay Pituitary gland, disorders. See also specific disorders, as Cushing's disease. in aged, 198 Pituitary gonadotrophin secretion, prostaglandins and Pityriasis versicolor, 1982: Julv, 877-878 Placebo efIects, in treatment of dementia resistance to antimicrobial therapy Platelet(s), aggregation, in septic lung injury Sept., 954 Pneumococcal pneumonia Pneumococcal vaccine Pm;umocystis carinii infection(s), trimethoprim-sulfamethoxazole for Pneumocystis pneumonia See also specific pathogens. atypical, tetracyclines for acute respiratory failure See also under specific agent, as Cyanide Poliovirus infection(s), in honlosexual nlen control of nosoconlial pneunlonia Polylnyalgia rheunlatica Popliteal artery, aneurysnl of Porphyria(s), photosensitivity and Positive end-expiratory pressure. See Pressure, positive end-expiratory 3: July, 787-792 in acid-base disorders, 198.3: July, 802-803 in chronic renal failure j\larch, 374-384 in acute tubular necrosis 1194 in nletabolic alkalosis, 198.3: July, 909 renal excretion of Inixed acid-base disorders 1232-1233 INDEX Pregnancy, diabetes and (Continued) nlanagelnent of, 1982: Nov., 1325-1346 herpes infectiuns during, 198.3: Sept., 1062-1063 hyperlipidenlia of, diet therapy for 1263 onset of diabetes during 1348-1358 positive end-expiratory, depressed cardiac output and, 198.3: j\Iay, 73.5-736 in ARDS, 198.3: May, 692-693 in nlechanical ventilation, 1983: j\lay, 601-617 physiology of, 198.3: j\Iay, 627 pulmonary arterial wedge honlosexual nlen Propionic acid, derivatives, for pain Propylene glycol, dennatitis fronl in inl1nediate hypersensitivity, 1981: Sept., 9.5.5 in septic lung injury, 1983: }VIay, 703-704 insulin secretion and Poisoning, management oC 1.983: Nov" 1279-1293. See also under specific agent, as Cyanide Poliovirus infection(s), in homosexual men control of nosocomial pneumonia Polymyalgia rhelllnatica, 1.981: Jan., 203 in aged Polvuria, 1.981: \larch Porphyria(s), photosensitivity and, 1.982: July Positive end-expiratory pressure. See Pressure, positice end-expiratory acid-base disorders, 1.983: July, 802-80:3 in chronic renal htilme, 1.981: ~Iarch, 4:3:3-4:3.5 in hyperaldosteronism, 1.983: July, 896 in hypoaldosteronism, 1.983: July metabolic alkalosis, 1.983: July, 906 in renal failure, 1.983: Nov., 1:3:37-1:3:38 in renal tuhular acidosis, 1.983: July diuretic-induced, 1.981: March, :300 hyponatremia with, 1.981 : March, 260-262 disorders serum, in mixed acid-hase disorders :3 INDEX Pregnancv, diabetes and (ContimlCdJ managcment of, 1.982: \10\'., 1325-1:346 herpes infecti,)l1s during, 1.983: Scpt., 1062-106:3 hyperlipidemia of, diet therapy fc)r, 1.982: March multiple insulin injections during, 1.982: Nov., 126:3 onset of diabetes during Sec Blood pressure. central venous. See Venous pressure. continuous positive airway, in mechanical ventilation, 1.983: :VI ay, 60.5-612 physiology o( 1.983: ~L;y pulmonary artery, monitoring of homosexual men, 1.983: Jan Propionic acid, derivatives, for pain, 1.982: Sept Propranolol, f,)r variceal bleeding Propylene glycol, dermatitis from, 1.981: Sept insulin secretion and, 1.981: July, 759-764 metabolism in lungs, 1.981. Jnlv-, 789-808 peptic ulcer disease and, 1.981: Jnly, 782 pro-inflammatory actions of, 1.981: July, 724 synthesis, arachidonic acid metabolism in. 1.981: July, 716-720 inhibitors of, anti-inflammatory agents as, 1.981: July hypertrophy of, in aged 1393-1394 in aged Protease inhibitor(s), in obstructive lung diseases Protein(s), antiviral, 1983: Sept., 1147-1162 dietary, effect on lipid nletabolisnl in lung secretions of sInokers Protein buffers Protein-calorie nlalnutrition, in acute respiratory failure Proton transport, in urinary acidification Protozoan infection(s), treahnent, 1982: 1av Sept., 1177 Inethods of physical therapy for Pseudolnelnbranous colitis, antibiotic-associated, 1982: NI ay See also specific agent, such as Carbenicillin. Pseudo-obstruction syndrOInes, chronic intestinal NI arch NI arch, 312 Psychological aspects, of insulin infusion pUlnps Psychopharnlacologic drugs aged, 198.3: Nlarch, 369 Psychotic reaction See also Lung(i;;) nlonit'oring of, in critically ill Pulnlonary artery hypertension Puhnonary aspiration, gastroesophageal reflux and Pulmonary circulations, prostaglandins in Pulnlonary conlplications, of acute respiratory failure Pulnlonary disease, chronic obstructive, radiographic features of interstitial, respiratory nluscle fatigue in airway responsiveness and chronic, acute respiratory failure in, 1981: May, 563-578 respiratory care for occupational, airways obstruction in 1181-1185 in acute respiratory failure hypertrophy of -HJ8 tetracyclines for, 1982: Jan" 299 trimethoprim-sulfamethoxazole for Protease inhibitor(s), in obstructive lung diseases Protein(s), antiviral, 1983: Sept., 1147-1162 dietary, effect on lipid metabolism in lung secretions of smokers Protein buffers Protein-calorie malnutrition, in acute respiratory failure Proton transport, in urinary acidification Protozoan infection(s), treatment, 1982: I\lay 536 in terminally ill, 1982: Sept., 1177 methods of physical therapy for, 1982: Sept,1122-1123 nocturnal Pseudo-Bartter's syndrome, prostaglandins and Pseudomembranous colitis, antibiotic-associated See also specific agent, such as Carhenicillin. Pseudo-obstruction syndromes, chronic intestinal Pseudo-parkinsonian reaction cutaneous T cell IYl11phoma,1982: Julv, 906-907 in psoriasis Psychogenic polydipsia Psychological aspects, of insulin infusion pumps Psvchopharmacologic drugs Psychosis, drug therapy f()r, 1982: Sept Psychotic reaction, to acute illness Pulmonary arterial wedg~ pressure Pulmonary aspiration, gastroesophageal reflux and Pulmonary circulations, prostaglandins in Pulmonary complications, of acute respiratory failure Pulmonary disease, chronic obstructive, radiographic features oC 1983: Nov., 1310 respiratory muscle filtigue in See also specific diseases. acute respiratory failure in, 1983: May, 657-668 airway responsiveness and, 1981: l\Jay, 473-487 cardiovascular performance in 629-645 exercise performance in Pulmonary ec/ema, permeability 1181-118 Puhnonary en1bolisl11 (Continued) 1983: Nov., 1179-1191 pain of See Ernphyserna. Puln10nary function, age-related changes Puln10nary hypertension, in chronic airflow obstruction Pulmonary infection(s), in aged 689-690 septic, mediators of, 1983: May, 701-715 Pulmonary management, of overdose patient Puln10nary radiology, in critical care medicine See also under Insulin, delivery. for insulin infusion PUVA. See Psoralen. Pyloric sphincter, motility of, effect of gastrointestinal horn10nes on 72&-728 for parasitic infections Pyruvate dehydrogenase deficiency, lactic acidosis and Pyrvinium pamoate, for parasitic infections Quaternium 15, dermatitis fron1 32-33 Radioactive iodine therapy, for hyperthyroidism, 1983: Mar., 502-503 INDEX Radiographic exalllination, puln10nary, in critical care 111edicine virus detection Radionuclide scan(s), in herpes simplex encephalitis cutaneous T cell lyn1-phon1a Reagent strips, for glucose n1easuren1ent Reagent(s), viral immune Reflectance meter(s), for self-n10nitoring of blood glucose Regressive dependency, reaction to acute illness) acid-base balance in aged, 1983: March, 473-474 n1anagement of, 1983: Nov., 1337-1339 oliguria and Renal function, age-related changes Renal insufficiency, antiInicrobial therapy and Pulmonary embolism (Continued) 1983: Nov., 1179-1191 pain of See Emphysema, Pulmonary function, age-related changes Pulmonary hypertension, in chronic airflow obstruction Pulmonary infection(s), in aged 689-690 septic, mediators oC 1983: May, 701-715 Pulmonary management, of overdose patient See also under Insulin, delivery. for insulin infusion Pyloric sphincter, motility of, effect of gastrointestinal hormones on 726-728 for parasitic infections Pyruvate dehydrogenase deficiency, lactic acidosis and Pyrvinium pamoate, for parasitic infections Quaternium 15, dermatitis from 32-33 Radioactive iodine therapy, for hyperthyroidism, 1983: Mar., 502-503 INDEX Radiographic examination, pulmonary, in critical care medicine virus detection Radionuclide scan(s), in herpes simplex encephalitis cutaneous T cell lymphoma Reagent strips, I()r glucose measurement Reagent(s), viral immune Reflectance meter(s), for self-monitoring of blood glucose Regressive dependency, reaction to acute illness acid-base balance in aged, 1983: March, 473-474 management of, 1983: Nov., 1337-1339 oliguria and Henal function, age-related changes Renal insufficiency, antimicrobial therapy and Renal rnechanisnls, of nletabolic alkalosis Renal sites, of urinary acidification Renal tissue, diseased, antinlicrobial pharnlacokinetics in See also under Acidosis. potassiunl depletion and Renal vascular regulation, prostaglandins and Renal water reabsorption, prostaglandins and Resin(s), bile-acid binding, for hypercholesterolernia See also under specific agent. conl-bination therapy for preventing Respiration, depressed, with narcotics, 1982: Sept See also Respiratory failure See also Lung. Respiratory acidosis. See Acidosis, respiratory. Respiratory alkalosis. See Alkalosis, respiratory. Respiratory care, comprehensive, for chronic obstructive lung disease corticosteroids in, 1983: May, 717-724 high-frequency ventilation in, 1983: May, 639 radiographic features of neonatal, maternal diabetes and Respiratory failure, acid-base ilnhalance in lnechanical ventilation in, 1983: rv1ay, 599-619 radiographic features of conlplications of, radiographic features of Respiratory nluscle training, in obstructive lung disease Respiratory syncytial virus infection(s) gas exchange in 173-186 nosocomial infections, 1983: Nov., 1260-1270 muscles of, failure of the ternlinally ill Retinoic acid, in acne Retinoid(s), in acne effect of pump therapy on oncogenic, 1983: Sept Rheumatic fever, pTophylaxis Rheulnatic syndrolnes Rheulnatoid arthritis, arachidonic acid metabolites and Rheumatoid factor, interference in IgM assays INDEX Renal mechanisms, of metabolic alkalosis Renal sites, of urinary acidification Rcnal tissue, diseased, antimicrobial pharmacokinetics in See also under Acidosis. potassium depletion and Renal vascular regulation, prostaglandins and Renal water reabsorption, prostaglandins and Resin(s), bile-acid binding, for hypercholestcrolemia See also under specific agent. combination therapy for preventing Respiration, depressed, with narcotics, 1982: Sept See also Respiratory failure See also Lung. Respiratory acidosis. See Acidosis, respiratory. Respiratory alkalosis. See Alkalosis, respiratory. Respiratory care, comprehensive, for chronic obstructive lung disease corticosteroids in, 1983: May, 717-724 high-frequency ventilation in radiographic features of neonatal, maternal diabetes and, 1982: I\'ov 669-684 muscle fatigue and Respiratory muscle training, in obstructive lung disease Respiratory syncytial virus infection(s) gas exchange in PneulllOnia( s); and specific pathogens. airway reactivity and the tenninally ill Retinoic acid, in acne Retinoid(s), in acne effect of pump therapy on Retrovirus(es), oncogenic, 1983: Sept Rhellmatic syndromes Rheumatoid arthritis, arachidonic acid metabolites and Rheumatoid factor, interference in IgM assays Rhinitis medicamentosa rosacea Rhinovirus infection(s), respiratory, 1.983: Sept viral respiratory infections }-81 disposition of, in liver disease viral respiratory infections RNA virus(es), oncogenic, 1983: Sept Rotavirus infection(s), gastroenteric, 1983: Sept Rotavirus vaccine Roundwonn infection, drug therapy for Run1ination syndron1e, behavioral therapy for Sept., 1054-1055 for pruritus, 1982: Sept., 1125 lactic acidosis and Salicylic acid, in acne Saline therapy, in ketoacidosis trilnethopriln-sulfan1ethoxazole for 238-240 RNA viruses and Scalded skin syndrolne Scan(s), perfusion lung Sept., 996-1000 in aged evaluation of esophagus, stomach, and duodenunl for variceal bleeding, 1.983: Nov., 1221-1222 progressive systenlic Secretory con1ponent, in lung secretions of slnokers propl Sedative(s), for pruritus, 1982: Sept., 1124 overdose, nlanagenlent of Seizure(s), grand n1al, lactic acidosis and acute respiratory failure Septic arthritis Septic shock, corticosteroids in, 1983: 1\1ay, 717-724 puln10nary injury and Sept., 944-948, 963-966 in herpes sin1plex encephalitis inlnlediate hypersensitivity SerUl11 sickness, drug-induced Sexual dysfunction Sexual function Shmllpoo(s), for seborrhea 1\1 ay 623-638 trinlethopriIn-sulfanlethoxazole for Hhinovirus infcdion(s), respiratory, 19&3: Sept viral respiratory infections liver disease viral respiratorv infections RNA virus(es), oncogenic, 1983: Sept Rotavirus infection(s), gastroenteric, 1983: S ept Sept., 104J Roundworm infectioll, drug therapy fur Rumination s}:ndrome, behavioral therapy for }-748 for pain Salicvlic acid, in acne Saline thcrapy Salmonellosis, chloramphenicol for, 1.982: Jan., 93 trimethoprim-sulfamethoxazole f(,r 238-240 H:'\IA viruses and management of Scalded skin syndrome Scan(s), perfusion lung, in pulmonary embolism Schizophrenia, drug treatment f()r, 1982: Sept., 996--1000 in aged evaluation of esophagus, stomach, and duodenum \' Secretory component, in lung secretions of smokers Secretorv diarrheas, pathophysiology, 1.982: Ma\ Sedative(s), for pruritus, 1982: Sept., 1124 overdose, management of Seizure(s), grand mal, lactic acidosis and, 1.983: July, 822 in herpes simplex encephalitis acute respiratory faillll'e, 1.983: Ma\ Septic shock, corticosteroids in, 1.983: May, 717-724 pulmonary injlll'Y and, 1.983: "''lay Serologic tests, in diagnostic virology, 1.983: Sept., 944-948 herpes simplex encephalitis, 1.983: Sept immediate hvpersensitivity, 1.981: Sept Serum sickness, drug-induced, 1.981: Sept., 1093 penicillin-induced, 1.983 Sexual dysfunction, in male diabetics 102 treatment of~ 1.982: July, 915-925 viral, 1.983: Sept., 1059-107:3 in homosexual men, 1.983: Sept Sezary syndrome, treatment of Shampoo(s), for seborrhea Shigella, properties of virulence, 1.982: May :38 trimethoprim-slllfamethoxazole for See also Ilerpes zoster Shock, respiratory distress syndrcHne after Shunt(s), intrapultnonary, effect on gas exchange, 198.3:~lav dietary, effect on lipid nletabo-lisll1, 1982:~!larch, 491 for hypercholesterolell1ia See also under specific diseases, as Psoriasis 118-120 viral infection, treatnlent of Lupus erythernatosus, systelnic. Sleep, disorders, in aged Sept., 980-982 in aged, 1983: March, 424 treatIllent for Slow-reacting substance of anaphylaxis (SRS-A), in inll11ediate hypersensitivity Snlallpox vaccine Nlay, 667-689 airway reactivity and, 1981: tvlav, 481 elast;se-antiela balance (Continued) in chronic renal hlilure intoxication, 1.981:~larch, 277 lo , clinical lnanifestations of serunl concentrations, high. See Hypernatrenlia. low. See Hyponatrelnia . osnlotic forces and Sodiunl-hydrogen exchange 111echanisnls Solar urticaria South Anlerican blastol11ycosis 39-40 for viral culture 169-173 Spider bites Spinal cord, lesions of, respiratory ll1uscle fatigue in, 1983: tvlay Splenic artery, aneurysnl of SPUtUll1 cultures Staphylococcal infections, penicillins for. See Penicillin(s), antistaphylococcal Staphylococcal pneulllonia Status asthl11aticus See also Corticost;roid(s). in acne biUEX Shingles, 1982: Illlv, 81O-IH2. See also Il e rpcs zoste r" Shock. respiralon' distress wndrome after Shunt(s), intrapulmonary, efFcct on gas exchange I())' hypercholesterolemia See also under specific diseases, as Psoriasis. in rheumatic diseases. See specific diseases. lesions, in lupus erythematosus Lupus erythematosus, systemic. Sleep, disorders, in aged treatment I,)r, 1982: Sept., 971-991 gastrointestinal function during Vlay, .558; 1982: Sept.. 980--982 in aged, 1983: March, 424 treatment Ill Slow-reacting substance of anaphylaxis (S1\S-A) airway reactivity and, 1.981: 'vlav, 481 elast;se-antiela Sodium, balance. in acute tubular necrosis Sodiulll, balance (Continued) iu chronic renal hlilure,1.'.J8J: '-larch renal tubular acidosis, 1(J83: July, 869--870 serum concentrations, high. See Hypernatremia. low. See Hyponatremia. osmotic /()rces and \Iarch, :307 lor metabolic acidosis Sodium colistimethate, 1982: Tan Sodium-hydrogen exchange n~t'chanisms Solar urticaria Solute diuresis, 1.981: March VI ay 39--40 for viral culture Spinal cord, lesions of, respiratory muscle hltigue in Spironolactone, 1.981: March, 296 in hyperaldosteronism Splenic artery, aneurysm of Sputum cultures Staphylococcal infections, penicillins for. See Penicillin(.\·), antistaphyiococcai. Staphylococcal pneumonia Status asthmaticus See also C()rticost~roid(s). in acne, 1982: Julv, 862-863 in etiology of perioral dermatitis Steroid(s) (Continued) in seborrhea disorders, 1981: Nov., 1269-1289 effect of gastrointestinal hormones Streptococcal pneun10nia Stress ulcer(s), bleeding from See Transient ischemic attack(s) 135 Sudden death, prostaglandins and See Trinwthoprin~ sulJamethoxazole Sulfonmnide(s) Sulfone(s), in acne Sun, cutaneous reaction to, treatment of 1149-1171 during sleep 69-73 in critically ill, 1983: Nov., 1348-1358 in respiratory failure, complications of Swine influenza vaccine, adverse reactions to 29-30 INDEX SY111pathetic inhibitor agents, effects, in diabetics Sylnpathomilnetic bronchodilators Symptom(s), control, in tel"minal care, 1982: Sept., 1161-1168, 1169-1183 with drugs, 1982: Sept., 971-1083. See also under specific sylnpton1. gastrointestinal, in the terminally ill Synovial fluid, infections, cephalosporins for Syphilis Systeinic disorders, lactic acidosis and See also Lupus erythematosus, systemic Takayasu's disease Tangier disease Tapewonn infection(s) T-cell deficiency syndromes Tardive dyskinesia, with antipsychotics Terminal illness Test(ing), laboratory. See under Laboratory and specific procedure Tetracycline(s) Steroid(s) (Continued) in seborrhea Stomach, acid secretion during sleep 1269-1289 eflect of gastrointestinal hormones Streptococcal pneumonia Stress ulcer(s), bleeding from 135 Sudden death, prostaglandins and See Trimethoprim-sulJamethoxazole Sulfonamide(s) Sulfone(s), in acne Sun, cutaneous reaction to, treatment of 1149-1171 during sleep Swine influenza vaccine, adverse reactions to -30 INDEX Sympathetic inhibitor agents, effccts, in diabetics Sympathomimetic bronchodilators Symptom(s), control, in tCl'minal care, 1982: Sept., 1161-1168, 1169-1183 with drugs, 1982: Sept., 971-1083. See also under specific symptom. gastrointestinal, in the terminally ill Synovial fluid, infections, cephalosporins for Syphilis Systeinic disorders, lactic acidosis and See also Lupus erythematosus, systemic Takayasu's disease Tangier disease Tapeworm infection(s) T-cell deficiency syndromes Tardive dyskinesia, with antipsychotics, 1.983: March Terminal illness Test(ing), laboratory. See under Laboratory and specific procedure Tetracycline(s) Tetracycline(s) (Continued) for rosacea Tetracycline hydrochloride, for intestinal protozoan infections Thallium-201 cardiac inlaging, in right ventricular enlargenlent Thoracic restrictive disease, respiratory muscle fatigue in Throat cultures See Platelet(s) Sept., 1098 in acute respiratory failure 1315-1316 with respiratory failure Thrombolytic agent(s), for pulnl0nary embolism Thromboxane(s), in septic lung injury Thymidine kinase, role in herpes infection Thymus gland, involution, aging and Thyroid function, tests of Thyroid gland, cancer of, in aged Thyroid hornlone(s), levels, in diagnosis of hyperthyroidisnl 61-73 resistance to Tinea barbae Tissue oxygenation, assessnlent of Tissue penetration, antimicrobial Tolerance, to antinlicrobials, overcoming herpes simplex encephalitis Tourette's syndrome, neuroleptics for Toxicity, decreased, in cOlnbination antimicrobial therapy Toxic reactions, to drugs 143 Traffic accidents, benzodiazepines and chronic obstructive lung disease Transhepatic embolization (THE), percutaneous, for variceal bleeding Transient ischelnic attack(s), in aged 20 respiratory distress syndrome after Traveler's diarrhea, prophylaxis acne Tricyclic antidepressants, for depression Tetracycline(s) (Continued) for rosacea Tetracycline hydrochloride, for intestinal protozoan infections Thallium-201 cardiac imaging, in right ventricular enlargement Thoracic restrictive disease, respiratory muscle fatigue in Throat cultures See Platelet(s) Sept., 1098 in acute respiratory failure 1315-1316 with respiratory failure Thrombolytic agent(s), for pulmonary embolism Thrombosis, arachidonic acid metabolites and, 1.981: July, 867-870 of cavernous sinus Thromboxane(s), in septic lung injury Thymidine kinase, role in herpes infection Thymus gland, involution, aging and Thyroid function, tests ()f~ 1983: March Thyroid gland, cancer of in aged Thyroid hormone(s), levels, in diagnosis of hyperthyroidism, 1983: ~Iarch, 501-502 in diagnosis of hypothyroidism 61-73 resistance to Tin~a barbae Tissue oxygenation, assessment of Tissue penetration, antimicrobial Tolerance, to antimicrobials, overcoming herpes simplex encephalitis Tourette's syndrome, neuroleptics for Toxicity, decreased, in combination antimicrobial therapy Toxic reactions, to drugs 143 Traffic accidents, benzodiazepines and chronic obstructive lung disease Transhepatic embolization (THE), percutaneous, for variceal bleeding Transient ischemic attack(s), in aged 20 respiratory distress syndrome after Trawler's diarrhea, prophylaxis acne Tricyclic antidepressants, for depression Tricyclic antidepressants (Continued) side effects or ]982: Sept hypertriglyceridelnia, 1982: March, 522-523 plasma, atherosclerosis and 72-74 for intestinal protozoan infections, 1982: May, 718 for shigellosis Tropical eosinophilia, 1981: Sept., 1066 Tropical sprue 80-83 in aged, 1983: March 428-429 outpatient therapy Tuberculous meningitis Tubulointerstitial disease(s), acute renal failure and See also CarcinOlna and specific types and regions. endocrine crisis and hormone-secreting, secretory diarrheas due to 21-25 lactic acidosis and Tun10ral calcinosis Twin studies, of diabetes 144-145 epithelial, in recurrent herpes infection Ulcerative colitis Sept., 1127-1128 for psoriasis See also Renal failure, chronic. pruritus in, 1982: Sept Urethral discharge, laboratory exalnination 29~300 Uric acid metabolism, clinical disorders of See also specific agent, such as Nitrofurantoin See Acidification, urinary. analysis of, in renal failure Uterus, infections, cephalosporins for Uveal tract, infections See also specific diseases, as Snwllpox vaccine Vaccine(s), adverse reactions to Vaccinia virus, recon1binant, 1983: Sept Vaginal discharge, laboratory exan1ination Tricyclic antidepressants (Continued I side effects of. 19>'2. Sep!. IO·Hl-]()4.j Trifluridine, 19f13: Sept hypertriglyceridemia, 1982: March, 522-523 plasma, atherosclerosis and 72-74 for intestinal protozoan infections, 1982: May, 718 for shigellosis Tropical eosinophilia, 1981: Sept., 1066 Tropical sprue, 1982: ~lay 80-83 in aged, 1983: March 428-429 outpatient therapy Tuberculous meningitis, 1982: 1\;1 ay Tubulointerstitial disease(s), acute renal failure and See also Carcinoma and specific types and regions. endocrine crisis and, 1983: ]\;ov., 1210-1212 hormone-secreting, secretory diarrheas due to Twin studies, of diabetes 144-145 epithelial, in recurrent herpes infection Ulcerative colitis Sept., 1127-1128 for psoriasis See also Renal j(Jilure, chronic. pruritus in, 1982: Sept U retInal discharge, laboratory examination 29~3(}0 Uric acid metabolism, clinical disorders of See also specific agent, sllch as Nitrofurantoin See Acidification, urinary. analysis of, in renal failure Uterus, infections, cephalosporins for Uveal tract, infections See also specific diseases, as Smallpox vaccine Vaccine(s), adverse reactions to Vaccinia virus, recombinant, 1983: Sept Vaginal discharge, laboratory examination 175-181 for antibiotic-associated pseudolnenlbranous colitis Varicella-zoster virus infection(s) aged, 1983: March, 438-440 renal failure and -947 treahnent of Vasoactive substances, prostaglandins and right ventricular enlargelnent Sept., 1059-1073 in hOlllosexual lnen Venous pressure, central, 1110nitoring of~in criticallv ill continuous positive pressure, cardiovascular function and ARDS, 1983: May, 693 physiology of Ventilation (Continued) spontaneous, physiology of Ventilation-perfusion inlbalance Ventilator(s), Inechanical. types of chronic obstructive lung disease Ventilatory response, during exercise See Wart. Vertigo, in aged Very low density lipoproteins (VLDL) -522 relation to low density lipoproteins Very low density lipoprotein rel11nants Nlarch, 393-395 in cholesterol-fed nlan Vibrio infection(s) Sept., 973-974 for viral infections Viral arthritis Viral gastroenteritis Sept., 1031-1058 in aged Viral serology INDEX Vaginitis, nonspecific for antibiotic-associated pseudomembranous colitis Varicella-zoster virus infe~tion(s), 1U82: July, 810-812 in immunocompromised host hemorrhage with -947 treatment of 131>1 in cor pulmonale right ventricular enlargement 299-300 treatment of~ 1982: July, 915--925 viral Venous pressure, central, monitoring oC in critically ill Ventilation, al\'eolar, abnormality of physiology of, 1983: May, 624 mechanicaL cardiovascular fimction and Ventilation (Continued) spontaneous, physiology of Ventilation-perfusion imbalance Ventilator(s), mechanical. types of 528-530 in chronic obstructive lung disease Ventilatory response, during exercise See Wart. Vertigo, in aged 520 relation to high density lipoproteins Very low density lipoprotein remnants ~-Very low density lipoproteins 393-395 in cholesterol-fed man Vibrio infection(s) 238-240 in herpes infections Viral arthritis Viral gastroenteritis larch, 287-289 in immunocompromised host Viral serology, 1983: Sept Virus(es), as vaccines, 198.3: Sept., 1129-1145 detennination of ilnnlunity to, 198.3: Sept., 96.5--966 drugs for Visceral aneurysnl for psoriasis, 1982: July, 788 for rosacea See Very low density lipoproteins (VLDL) See also Body water. balance, in respiratory failure 3: Nlarch, 337-338 INDEX \Vhite blood cell(s). See Leukocyte(s) vVhite classification, to assess fetal risk in diabetics Sept., 967 \Vound healing fanlilial dysbetalipoproteinenlia, 1982:~larch, 450 in rponogenic hyperlipidelnias diet, urticaria and endoscopic features, 1982: Nlay, 647, 651 radiologic exanlination for ZINC, deficiency, in aged Sept., 1048-1051 infections. See Viral infection(s). laboratory diagnosis of Visceral aneurysm >-866 for psoriasis, 1982: July, 788 for rosacea Vitamin D-resistant rickets Very low density iipoproteins (VLDL) WART(S). treatment of See also Body water. halance, in respiratory failure Weight, excess. See Obesity. loss, in aged INDEX White hlood cell(s). See LCllkocyte(s) \Vhite classification, to assess fetal risk in cliabetics Sept., 967 Wound healing 4S0 in monogenic hyperlipidemias diet, urticaria and Yersinia enteritis, 1982: 1\1 ay, 639-653 endoscopic features Zollinger-Ellison syndrome, secretory diarrh ea in